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ABSTRACT 
The apolipoproteins play critical roles in lipid transport, lipid metabolism and the 
pathophysiology of dyslipoproteinemias, most importantly atherosclerosis. ApoA-1 is a 
representative member of the family of exchangeable apolipoproteins and the major 
apolipoprotein of high density lipoprotein (HDL). HDL is responsible for the pathway of 
reverse cholesterol transport and the only particle capable of removing cholesterol from 
peripheral cells for transport to the liver. 
The sequences ofthe exchangeable apolipoproteins contain 11122 residue tandem 
sequence repeats forming amphipathic a-helices that are believed to be responsible for 
lipid binding. The consensus sequence peptide (CSP) for this repeat was derived based on 
the characteristic residue distribution of the exchangeable apolipoproteins. The derived 
consensus sequence containing motifs A, (PLAEELRARLR), and B, (AQLEELRERLG), 
represent an idealized lipid binding model and fundamental structural motif of the 
exchangeable apolipoproteins. 
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The recombinant CSP-ABAB peptide was successfully expressed in E. coli and 
purified. Circular dichroism showed that CSP-ABAB is ~62% a-helical, i.e.~27 residues 
of 44 residues are in helical conformation. The CSP-ABAB peptide was successfully 
15N, 13C labeled and the detailed tertiary structure was explored by NMR spectroscopy. 
The peptide 's backbone and side-chain resonances were successfully assigned and ten 
water refined structural conformers of CSP-ABAB were generated. 
The ten structural conformers all employ anti-parallel helical conformation m 
solution. Hydrophobic inter-helical interactions play a major role to stabilize the anti-
parallel helical hairpin conformation. There are also intra-/inter-helical salt bridges 
present on the surface of the CSP-ABAB molecule providing additional stabilization. The 
structural features of the NMR structures suggest a lipid binding model ofCSP-ABAB. 
When lipids are introduced, the exposed hydrophobic ridge contributed by the 
twelve leucine residues firstly bind to the lipids. At the same time, a hydrophobic 
concave surface created by the four alanine residues at the center of the interface is 
accessed by the introduced lipids. These two steps open the anti-parallel helical hairpin 
conformation to form a fully extended a-helix. Similar hydrophobic inter-helical 
stabilization interactions and new intra-/inter-helical salt bridges between two different 
CSP-ABAB molecules are reformed to stabilize the 'double-belt ' arrangement. 
This lipid binding model of CSP-ABAB sheds light on the lipid binding of apoA-I 
and the mechanism ofHDL formation. 
- Vll-
TABLE OF CONTENTS 
TITLE 
COPYRIGHT PAGE 
READER'S APPROVAL PAGE 
DEDICATION PAGE 
ACKNOWLEDGEMENTS 
ABSTRACT 
TABLE OF CONTENTS 
LIST OF TABLES 
LIST OF FIGURES 
LIST OF ABBREVIATIONS 
Chapter 1. Introduction 
II 
Ill 
IV 
v 
VI 
viii 
Xlll 
XIV 
XV Ill 
1.1 Overview of lipoproteins and lipoprotein metabolism .. ... ........ . ........ . 1 
1.1.1 Overview of lipoproteins ................... ....... ........................ 1 
1.1.2 High density lipoproteins (HDL) and reverse cholesterol transport 
(RCT) ... ................ ... .... . ......... ...... .......................... . ... 5 
1.2 Exchangeable apolipoproteins and its peptide models ....................... 8 
1.2.1 Exchangeable apolipoprotein ................. .... ....................... 8 
1.2.2 Exchangeable apolipoprotein apoA-1 ................. . ..... .. .......... 9 
1.2.2.1 apoA-1 synthesis ...................... .... ........................ 9 
1.2.2.2 apoA-1 function ....................... ...... . . . .......... . . .... 1 0 
1.2.2.2.1 Lipid binding ........... . ............ .. ... .. .... . .... 1 0 
- viii -
1.2.2.2.2 LCAT activation ........... .. ............ . ........... 11 
1.2.2.2.3 ABC-AI acceptor ........ . .... .. .................... 11 
1.2.2.2.4 SR-B1 binding ... .... . . . .... . .. .......... . ... . ...... 12 
1.2.2.3 apoA-1 structure ........ . .. ... ...... .. . .. . . ... .......... .. .. . ... 12 
1.2.2.3.1 Secondary structure model. .................... .... 13 
1.2.2.3.2 X-ray structure ofC-terminal truncated apoA-1 
........... .... ...... . .. . . . ... . ................ . .......... 16 
1.2.3 Consensus sequence peptide models of exchangeable 
apolipoproteins ............... . ....................... .. ............... . ... 18 
1.3 Summary of previous contributions ofthe structural studies of 
CSP-ABAB . ... ........... .. . ...... ......................... . .. ..... .. .......... .. 21 
1.4 Aims and outline of this study ... . ................. ....... . ...... ......... . .. .. 21 
Chapter 2. Materials and Methods 
2.1 Materials ........................ . ........................... . ......... . ........... 24 
2.2 Circular dichroism spectroscopy .......................... .. ................... 25 
2.2.1 Principles of circular dichroism ........................... .. .. .. ........ 25 
2.2.2 Sample preparation ......... . ..................... . ..... .... .. ... . . ...... 30 
2.2.3 Data collection and analysis ...... , ................................. .. ... 30 
2.3 Nuclear magnetic resonance spectroscopy (NMR) ........................... 31 
2.3.1 Theoretical background ofNMR ............ . ..... .. .............. .. ... 31 
2.3.2 Sample preparation ............. ... ............. . ........................ 33 
2.3.3 NMR data collection and processing . ...... ....... ...... ............... 33 
- ix-
2.4 The expression and purification system of consensus sequence peptide 
(CSP-ABAB) .............................. . ......................... .. .......... 36 
2.4.1 Construction ofCSP-ABAB expression vector. ... . ............... 36 
2.4.2 Ligation ............................................ . . ... ........ . ....... 42 
2.4.3 Transformation and expression ........ .. .... .. .......... .. ........ .. .42 
2.4.4 Inclusion body preparation, cleavage and purification .......... . .44 
2.4.5 High performance liquid chromatography ......................... .45 
2.4.6 Mass spectrometry ............................. . .... .. .......... . ..... .46 
2.4.7 Amino acid analysis ............................... . .................. .46 
Chapter 3. Expression and purification of recombinant CSP-ABAB 
3.1 Expression of recombinant CSP-ABAB ...................... ... ......... . .. .48 
3.1.1 Construction the CSP-ABAB plasmid .............................. .. .48 
3.1.2 Optimization ofthe expression cell line and the IPTG induction 
time ........... .... .............. .. . .... ....................... . ........... . 51 
3.1.3 Recombinant protein large scale expression in E. coli cells with 
IPTG induction .................................................. .. . ....... 53 
3.2 Purification of recombinant CSP-ABAB .............. ... ............. .. ..... 54 
High-performance liquid chromatography (HPLC) .... ..................... ...... 58 
Mass spectrum for unlabeled CSP-ABAB ................................... 60 
Mass spectrum for 15N labeled CSP-ABAB ........................... . .... . 60 
Mass spectrum for 13C and 15N labeled ABAB ...................... . .. .. .. 60 
Quantitative amino acid analysis ............................................ . 64 
- X -
3.3 Circular dichroism studies of recombinant CSP-ABAB ..... ... .... .... .. 65 
Chapter 4. NMR structure determination 
4.1 Resonance assignment ........................................................................ 73 
4.1.1 Resonance assignment of backbone atoms ........... ........... ........ .... ..... ... 73 
4.1.2 Resonance assignment of side-chain atoms ....................... ..... ............. 80 
4.2 Structural information ............... . ...... .. ................. ....... .. . ..... ...... ........ . .. 84 
4.2.1 Dihedral restraints .................... ........... ......... ....... ... ..... ... . ......... .. 84 
4.2.2 Distance restraints ....... .. ................................ ............. ...... . ......... 87 
4.3 Structure determination ............... .................... ..... ......... ... ......... . ... .... ... 87 
4.3.1 Determination of the secondary structure ......................... .... ... . .. ... ..... 87 
4.3.2 Determination of the three-dimensional structure ......... ... ... .... ... ...... .. ... 94 
4.4 Structure analysis of the calculated structure ensemble ............... .. ................ 98 
Chapter 5. Summary and discussion 
5.1 Summary of this thesis study ... . .. ............... ............... ........ .......... .. ....... 118 
5.2 Comparison ofthe NMR structure ofCSP-ABAB with the structures solved by 
dynamic simulation .. ........... .......... ...... ..................... .... .......... ... .... .... 125 
5.3 Comparison ofthe NMR structure with the ~(185-243) apoA-1 structure solved by 
X-ray crystallography ........... .... ... .... ...... ................. ...... .. ...... ............. 130 
5.4 Lipid binding model proposed based on the NMR structure ofCSP-ABAB ......... 136 
5.5 Discussion of the limitations of the NMR structure ensemble ................. .. .... .... .. .... 138 
5.6 Future studies .................... ....................... ........... . .. . ..... .... ............... 140 
LIST OF JOURNAL ABBREVIATIONS ......................... . . .... ...................... 142 
- Xl-
REFERENCES ............................................................... . ........ ... ..... . ... 144 
CURRICULUM VITAE ................................... . ......... ..... .... .. ..... ... ... . ...... 150 
- Xll-
LIST OF TABLES 
Table 1.1. Properties of plasma lipoproteins ........... . . .. ........ .. .. . ... .. ........... ........ . 3 
Table 4.1. Chemical shift assignments for CSP-ABAB (pH 5.5, 293K, ppm) ... ... .... .... 82 
Table 4.2. Protein backbone torsion angle table ofCSP-ABAB ........ . ................... .. 85 
Table 4.3. Secondary structure of CSP-ABAB indicated by NMR data per residue ... .. ... 90 
Table 4.4. The secondary structure prediction of CSP-ABAB ... .. ... ... ........... ... ......... .. 92 
Table 4.5. Structural statistics for CSP-ABAB structure ensemble ..... .. .................. 1 00 
Table 5.1. Salt bridge interactions present in each individual structure conformer. ..... 123 
Table 5.2. Salt bridge interactions pattern present in the structures by dynamic 
simulation ........................................................ . ... .. .......... . .. . ... 126 
- xiii -
LIST OF FIGURES 
Figure 1.1. Plasma lipoprotein metabolism pathways .... .... ........ ....... ..... ....... . ..... .4 
Figure 1.2 High density lipoprotein (HDL) metabolism and reverse cholesterol transport 
(RCT) pathway ............ ...... ..................... . ......... .. .................. . .. . 7 
Figure 1.3 The helix distribution of apoA-1 ............................ ... ........ .. ........ .... 1 0 
Figure 1.4 The secondary structure model by sequence analysis ....... ........ .. ......... .. 14 
Figure 1.5 The secondary structure model ofapoA-1 refined from mutation, deletion and 
terminal truncation studies . . ............................... . ... ... ............ . ..... . 15 
Figure 1.6 The overall structure of ~ (185-243) apoA-1 dimer by X-ray . . .......... . ..... 17 
Figure 1.7 The consensus sequence homology A and B derived from the sequence 
analysis and amino acids distribution comparison among the exchangeable 
apoliporoteins apoA-1 , apoA-IV and apoE ...... .... . .............. ... .. .. ....... . 19 
Figure 1.8 Top view of space-filling model of the consensus sequence AB ............... 20 
Figure 2.1 Standard curves for a-helix, ~-sheet and random coil from four peptides . ... 28 
Figure 2.2. CSP-ABAB expression and purification strategy ........... ... ................... 37 
Figure 2.3 Insert and vector used for CSP-ABAB expression ............. ...... ......... . ... 38 
Figure 2.4 DNA sequences of primers used for CSP-ABAB expression ................. . 39 
Figure 3.1 1.8% T AE agarose gel showing the insert (cut ABAB) after double digestion 
by restrictions enzymes HinD III and EcoRJ ............ .. ........ . .............. .49 
Figure 3.2 0.8% TAE agarose gel showing the backbone (pT.tviHa) before and after 
double digestion by restrictions enzymes HinD III and EcoRJ ..... .. ... . ....... 50 
Figure 3.3 DNA sequence of the E.coli clone containing the correct ABAB insert DNA 
-XIV-
sequence including the HinDIII site, methionine, the ABAB insert sequence, 
three stop codons and the EcoRI site .............. .. ........... ...... ..... . ...... 51 
Figure 3.4 Tricine gel electrophoresis of recombinant protein expression .......... . ..... 55 
Figure 3.5 Tricine gel of recombinant protein cleavage and purification .. ................ 57 
Figure 3.6 Representative ofHPLC chromatograph . . ......... ... .......... ....... ... .. ..... 59 
Figure 3.7 A Mass spectrum ofthe collected peak 1 fraction ofthe unlabeled CSP-
ABAB ............ ..... ...................................... ..... ........ .. ....... . 61 
Figure 3.7 B Mass spectrum ofthe collected peak 1 fraction ofthe 15N labeled CSP-
ABAB ........................................ ....... ............. .. ...... .. ........ 62 
Figure 3.7 C Mass spectrum ofthe collected peak 1 fraction ofthe 15N, 13C labeled 
CSP-ABAB .. ....... ..... ..... .. ........ ............ ... . ......... . .. ..... . ..... ..... 63 
Figure 3.8 A representative HPLC chromatograph ofthe quantitative amino acid 
analysis used to determine the concentration ofCSP-ABAB ...... ... ...... . .... 64 
Figure 3.9 Quantitative amino acid analysis results of purified CSP-ABAB ... ....... . .. . . 65 
Figure 3.10 Far-UV CD spectra of CSP-ABAB in 5 mM PB with pH 7.4 .................. 67 
Figure 3.11 The mean residue molar ellipticity of CSP-ABAB peptide from 0.005 mg/mL 
to 0.5 mg/mL in 5 mM PB with pH 7.4 ............ .......... .. ... . ...... . .. . ...... 68 
Figure 3.12 The a-helical content ofCSP-ABAB peptide from 0.005 mg/mL to 
0.5 mg/mL in 5 mM PB with pH 7.4 . .. .. .. .... ....... ..... .... ... ... .......... .... 69 
Figure 3.13 The far-UV CD spectra ofCSP-ABAB peptide at 0.2 mg/mL in 5 mM PB 
with pH 5, 6, 7.4 .............. .......... ... ............................... . .......... . 70 
Figure 3.14 Melting curves ofCSP-ABAB peptide with different concentrations at pH 5 
-XV-
and 7.4 ............................................................ . .................... 72 
Figure 4.1 The 1H-15N HSQC spectrum ofCSP-ABAB (pH 5.5, 293K) ..... ... .. . .... . ... 74 
Figure 4.2 Two glycine residues on the 2D 1H-13C HSQC spectrum ofCSP-ABAB . 
.............................................................................. .. ....... . .... 76 
Figure 4.3_A 2D Assigned 1H,15N HSQC spectrum ofCSP-ABAB (pH 5.5, 293K) . 
...... . ............................ . . .. .. . .. . . ... ............ . ...... ... ...... .. .. . ........ . . 78 
Figure 4.3_B 2D Assigned 1H, 15N HSQC spectrum ofCSP-ABAB (pH 5.5, 293K) . 
.. ... .. ... ... .. .. .. .................................... ..... .. : ............... .. ..... ... .... 79 
Figure 4.4 CH plane of the 3D HCCH-TOCSY spectrum of CSP-ABAB at 13C 42.52 
ppm .............................................................. ... ........ . .......... . 81 
Figure 4.5 The structure calculation flowchart . ... ............... .. .... ......... ..... ..... ..... 96 
Figure4.6 The 10 water refined structure models of CSP-ABAB were superposed with 
only the backbones displayed ...................... ... ........... ....... ...... . .. .. 99 
Figure 4.7 The energy minimized average (em_ave) structure ofthe 10 conformers is 
represented as secondary structure . ..... ............................... .. ....... 1 01 
Figure 4.8 The hydrophobic interface ofthe energy minimized average (em_ave) 
structure ofthe 10 conformers ........ ................ ........ .......... .. ....... .. 102 
Figure 4.9 The hydrophobic ridge of the energy minimized average (em_ave) structure . 
... .. ... ................................................ . .......... ..... .. ..... . .. ....... 103 
Figure 4.10 Structure conformer one and its salt bridges ....... ....... ... .......... ... ... .. . 105 
Figure 4.11 Structure conformer two and its salt bridges ............................ .. ...... 1 06 
Figure 4.12 Structure conformer three and its salt bridges .... ................... . .... ....... 107 
- XVl-
Figure 4.13 Structure conformer four and its salt bridges ............. ....... ........ . ....... 1 08 
Figure 4.14 Structure conformer five and its salt bridges ..... ............ .... .. ... .... ..... . 1 09 
Figure 4.15 Structure conformer six and its salt bridges ..... . ............................... 110 
Figure 4.16 Structure conformer seven and its salt bridges ....................... . ......... . 111 
Figure 4.17 Structure conformer eight and its salt bridges .. ............. .................. .. 112 
Figure 4.18 Structure conformer nine and its salt bridges .................. ......... ..... .... l13 
Figure 4.19 Structure conformer ten and its salt bridges ..................................... 114 
Figure 4.20 Ramachandran plot of the 10 water refined conformers ofCSP-ABAB . 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115 
Figure 5.1 The helical wheel view ofthe suggested salt bridge pairs ofCSP-AB 
sequence ..... . ............ .. .................. . ...... .... ........... . ....... .. ........ .. 120 
Figure 5.2 CSP-ABAB structures generated by dynamics simulation .. ........ ............. 127 
Figure 5.3 AB homology~ (185-243) apoA-1 structure solved by X-ray crystallography 
and the salt bridges between the two apoA-1 monomers ... . . ............ ... ... 131 
Figure 5.4 Salt bridge interaction details within the~ (185-243) apoA-1 monomer. 
............... ....... ..................................... ...... . .... . .. .... ..... . ...... . 133 
Figure 5.5. Hydrophobicity representation ofthe surface ofCSP-ABAB ... ....... ....... l35 
Figure 5.6. Proposed lipid binding model ofCSP-ABAB ........ .. ..... . .................... 141 
- XVll -
LIST OF ABBREVIATIONS 
ABCAI: ATP-binding cassette transporter ABCA1 
ABCGI: ATP-binding cassette sub-family G member 1 
ACN: Acetonitrile 
ApoA-I: Apolipoprotein A-I 
ApoA-IV: Apolipoprotein A-IV 
ApoB-48: Apolipoprotein B-48 
ApoB-1 00: Apolipoprotein B-1 00 
ApoE: Apolipoprotein E 
ApoLp-III: Apolipophorin-III 
ARIA: ARIA: automated NOE assignment and NMR structure calculation 
BMRB: Biological Magnetic Resonance Bank 
BOG: n-Octyl-P-D-glucopyranoside 
CCPNMR: CoUaborative Computing Project for NMR 
CD: Circular dichroism 
CE: Cholesterol ester 
CETP: Cholesterol ester transfer protein 
CNBr: Cyanogen bromide 
COSY: Correlation spectroscopy 
CSP: Consensus sequence peptide 
CY ANA: Combined assignment and dynamics algorithm for NMR applications 
Da: Dalton 
- XVlll-
HDL: High-density lipoprotein 
HPLC: High-performance liquid chromatography 
HSQC: Heteronuclear single quantum coherence spectroscopy 
IDL: Intermediate-density lipoprotein 
LCAT: Lecithin-cholesterol acyltransferase 
LDL: Low-density lipoprotein 
LDLR: Low-density lipoprotein receptor 
NMR: Nuclear magnetic resonance 
NOE: Nuclear overhauser effect 
MW: Molecular weight 
MWCO: Molecular weight cut-off 
PBS: Phosphate buffered saline 
PCR: Polymerase chain reaction 
ppm: Parts per million 
RCT: Reverse cholesterol transport 
RMSD: Root-mean-square deviation 
T AE: Tris base, acetic acid and EDT A 
TF A: Trifluoroacetic acid 
TFE: 2,2,2-trifluoroethano I 
TG: Triglyceride 
TMSP: Trimethylsilyl propanoic acid 
TOCSY: Total correlation spectroscopy 
- XlX-
VLDL: Very low-density lipoprotein 
SR-BI: Scavenger receptor class 
-XX-
Chapter 1 Introduction 
1.1 Overview of lipoproteins and lipoprotein metabolism 
1.1.1 Overview ofLipoproteins 
Cardiovascular disease or heart disease is the disease that involves the heart or blood 
vessels (arteries and veins). [Maton, et aL , 1993) Such diseases are the leading cause of death in 
the United States [Kochanek, et aL , 2009l . Most lipids are insoluble in blood. However, lipids 
can be incorporated into complexes through interaction with specific proteins for 
transport in blood as a lipoprotein complex. The proteins in the blood interacting with the 
lipids to form the lipoprotein complex are called apolipoproteins. A clear understanding 
of the pathophysiology of cardiovascular diseases depends on our knowledge of the 
lipoproteins, their apolipoproteins and their metabolism. 
Lipoproteins are responsible for transporting phospholipids (PL), triacylglyceride (TG), 
cholesterol and cholesterol esters (CE) among the liver, the intestine and the peripheral 
tissue [Smaii, I992l. Usually, lipoproteins are composed of a neutral lipid core that is 
composed of triglyceride and cholesterol esters surrounded by a surface monolayer 
coating of phospholipids, free cholesterol and the apolipoprotein components. The 
apolipoprotein components fall into two classes; the nonexchangeable apolipoproteins 
and exchangeable apolipoproteins. The nonexchangeable apolipoproteins apoB48 and 
apoB 100 remain with the core particle from secretion through the cellular uptake and 
catabolism. The exchangeable lipoproteins such as apoA-I, apoA-II, apoA-IV, apoC-I, 
apoD and apoE may transfer between the lipid-free state and different lipoprotein classes 
during the course of lipoprotein metabolism. 
- 1 -
Lipoproteins are categorized into five major classes based on their density and size 
[Table 1.1]. They are chylomicrons (CM), very low density lipoprotein (VLDL), low 
density lipoprotein (LDL), intermediate density lipoprotein (IDL) and high density 
I. t · (HDL) [Atkinson&Small , 1986] 1popro em . 
Lipid transport and lipoprotein metabolism is divided into two pathways, the exogenous 
pathway and the endogenous pathway, determined by whether the lipoproteins in 
question are composed mainly of dietary (exogenous) lipids or whether they originated in 
the liver (endogenous). The different classes of lipoproteins function in different lipid and 
lipoprotein metabolism pathways. In the exogenous pathway, chylomicrons are 
responsible for lipid absorption and delivery oftriacylglyceride (TG) and (fatty acid) FA 
to adipose and muscle tissue. In the endogenous pathway, VLDL, IDL and LDL are 
responsible for the lipid transport and delivery. HDL is responsible for removing 
cholesterol from extra-hepatic tissues. During lipoprotein metabolism, the lipoproteins 
circulate in the blood stream, with the lipid content varying and the exchangeable 
apolipoproteins transfer from one class to another. 
- 2 -
Table 1.1 Properties of plasma lipoproteins. 
Lipoproteins Diameter Density Major core lipids Apoproteins 
' (g/cm3) (A) 
CM ;::::: 2,000 < 0.93 Dietary A-1, A-11, A-
triacy lglycero ls IV, B48 
CM remnant ;::::: 1,000 < 1.006 Dietary B48, E 
cholesterol esters 
VLDL ;::::: 600 0.93- Endogeneous B100, C, E 
1.006 triacylglycerols 
IDL ;::::: 350 1.006- Endogeneous B100, E 
1.019 cholesterol esters 
LDL ;::::: 220 1.019- Endogeneous B100 
1.063 cholesterol esters 
HDL ;::::: 80-120 1.063-1.21 Endogeneous A,C,D,E 
cho lestero 1 esters 
Table revised from [Small1992, Stryer 1988}. 
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Exogenous pathway Endogenous pathway 
Cholesterol 
Chylomicrons Remnants 
B-48 Q <O B48 no c~ D E ao 
I 
Plasma LCAT 
Adipose tissue, muscle Adipose tissue, muscle 
Figure 1.1 Plasma lipoprotein metabolism pathways. The lipid core ofthe lipoprotein 
particles are colored yellow and hydrophilic surface of the lipoprotein particles are 
colored green. Figure adapted from [Brown, MS. and Goldstein, J L ,1987}. 
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1.1.2 High density lipoproteins (HDL) and reverse cholesterol transport (RCT) 
High density lipoproteins (HDLs) are heterogeneous lipoproteins that originate from the 
l. [Hamilton RL, et al. , 1976] d · t t" [Green PH, et al. , 1978] N t HDL · d" "d 1 d th 1ver an m es me . ascen 1s a ISCOl a an e 
mature HDL is a spherical particle. Through the action of the enzyme lecithin cholesterol 
acyl transferase (LCAT), the cholesterol in the HDL particle is converted to cholesterol 
ester, and the discoidal HDL are converted to spherical HDL. HDL is responsible for the 
whole pathway of reverse cholesterol transport and it is the only particle capable of 
removing cholesterol from the peripheral cells for transport to the liver. HDL removes 
cholesterol from peripheral tissues and delivers cholesterol to the liver for reutilization. 
Some of this delivered cholesterol is transformed to bile acids. The bile acids, together 
with the some free cholesterol in liver is excreted into bile. 
As the major apolipoprotein component ofHDL particles, apoA-I is synthesized in the 
liver and intestine. And it play an important role in the reverse cholesterol transport 
pathway. The reverse cholesterol transport pathway begins at the liver. The liver 
synthesizes and secretes lipid-free/poor apoA-I which can quickly recruit lipid and free 
cholesterol through the hepatocyte ATP binding cassette AI (ABC-AI) transporters to 
form the nascent discoidal HDL particles [Rader, DJ , 20061 . The nascent discoidal HDL 
particle is composed of a phospholipids bilayer surrounded by two or more apoA-I 
molecules. Lipid-poor apoA-I can also promote the efflux of cholesterol from hepatocyte 
cells and peripheral cells through ABC-AI. ABC-AI can also interact with apoA-II and 
E d. h 1" "d · [Kathryn E eta! 2006] apo to me mte t e 1p1 recrmtment process ' ., . 
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Other than ABC-AI , There are also other ATP-binding cassette cholesterol transporters 
that control the delivery and disposal of cellular cholesterol, such as ABC-Gl. ABC-GI 
is a homodimeric half-transporter that mediates the export of cellular cholesterol to the 
lipidated lipoprotein particles, such as HDL and other lipoprotein particles but not to 
l. "d fr A I [Wang N, et al., 2006, Vanghan AM, et al. , 2006] ABC AI rt 1" "d A I 1p1 - ee apo - . - conve s 1p1 -poor apo -
to nascent lipoproteins that become partially lipidated and then are capable of accepting 
chole$terol exported by ABC-Gl. These two transporters act synergistically to remove 
cholesterol from cells. [Vanghan AM, et al., 2006, Geli ssen IC, et al., 2006] 
ApoA-1 can activate LCAT in plasma, which converts free cholesterol (FC) into 
cholesterol ester (CE). Mature HDL is gradually formed with the action ofLCAT, as the 
free cholesterol in the HDL particle is converted to the more hydrophobic CE [Fielding, CJ, et 
al. , 19721 . LCAT may also have other activators like apoC-I or apoD [Steyrey, E. and G.M. Kostner, 
19881 on the discoidal nascent HDL particle. With more cholesterol ester in the mature 
HDL particle core, the discoidal HDL particle becomes spherical HDL. Some CE is 
transferred to the apoB-containing lipoproteins such as VLDL in exchange for 
phospholipids and triglycerides through the action of cholesteryl ester transfer protein 
(CETP). The apoB-containing lipoprotein VLDL, will be gradually transformed to IDL 
with more TG being hydrolyzed to free fatty acids, and finally to LDL. The LDL' s major 
lipid component will be CE and it will be taken up by the liver through the LDL receptor. 
In addition to transferring its CE to the apoB-containing lipoproteins, HDL can also 
transfer its CE to the liver directly via the scavenger receptor class-B, type I (SR-BI) 
[Krieger, M, 19991. In liver, cholesterol ester is converted back to free cholesterol, some 
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h 1 1 . d b"l "d [Javitt NB 1994] Th b"l "d h . h c o estero rs converte to 1 e acr s · . e 1 e acr s, toget er wrt some free 
cholesterol, will be secreted into the bile for removal. HDL is usually thought of as the 
"good cholesterol" for its key function in mediating reverse cholesterol transport. The 
disease atherosclerosis is characterized by increased levels of non-HDL lipoproteins. 
Reduced HDL cholesterol is one of the key risk factors resulting in atherosclerosis and 
cardiovascular disease [Shah, Kaul , eta!. , 20011 . 
Peripheral Tissue 
Liver ~ 
__:~~--(}1--e]-~·:;· 
IIDU LCAT 1101.3 LCAT nascent 
---- CE~C HDL 
ll CETP 
--------
VLDL LPL IDI, LPL LDL 
Upl;akc 
Figure 1.2 High density lipoprotein (HDL) metabolism and reverse cholesterol 
transport (RCT) pathway. [Modifiedfrom Briggs MR 2004 Chemical Review]. 
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1.2 Exchangeable apolipoproteins and its peptide models 
1.2.1 Exchangeable apolipoproteins 
As introduced previously, apolipoproteins are divided into two groups, exchangeable 
and non-exchangeable apolipoproteins that differ from each other as to whether the 
apolipoproteins remain with the lipoprotein particle from secretion to cellular uptake and 
degradation. Exchangeable apolipoproteins like apoA-I, apoA-II, apoCs and apoE are 
soluble in the aqueous environment. Non-exchangeable apolipoproteins like apoB 100 and 
apoB48 are insoluble in aqueous solution. 
All exchangeable apolipoproteins except apoA-IV are coded by four exons [Luo cc, et at, 
19861
• Exon 3 codes the N-terminal of the exchangeable apolipoproteins. The genomic 
structure of exon 4 contains tandem 11 or 22 amino acid repeats. These 11122-mer 
repeats can be subdivided into two 11 amino acid sub repeats. ApoA-1 , apoE and apoA-
IV all contain tandem 11/22 sequence repeats [Nolte and Atkinson, 19921. Primary sequence 
analysis of these exchangeable apolipoproteins reveals that these sequence repeats have 
the potential to form class A amphipathic a-helices [Segrest JP, et at. , 19741. A class A 
amphipathic helix is defmed as an a-helix with the opposing polar and nonpolar faces 
oriented along the long axis of the helix. When their sequence is viewed on a helical 
wheel, it contains a hydrophobic face comprised of non-polar and a hydrophilic surface 
comprised of polar and charged amino acids. The negatively charged residues are located 
in the middle of the polar face, and the positively charged residues sit between the polar 
and nonpolar faces. 
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This structural characteristic ofthe exchangeable apolipoproteins, one hydrophobic face 
and another hydrophilic face, is consistent with their function to solubilize hydrophobic 
lipids thus making the lipoprotein particle soluble and stable in the blood stream. The 
sequence repeats and the structural motif of the amphipathic helix are thought to be the 
common structural and functional motif of the exchangeable apolipoproteins. 
1.2.2 Exchangeable apolipoprotein apoA-1 
As discussed, apoA-1 is responsible for the entire reverse cholesterol transport pathway. 
It has multiple functions through the reverse cholesterol transport pathway. 
1.2.2.1 ApoA-1 synthesis 
The plasma form ofapoA-1 is a single polypeptide containing 243 amino acids [Figure 
1.3]. The gene encoding apoA-1 belongs to the apolipoprotein multigene superfamily. 
Exon 3 encodes residues 1-43 and exon 4 encodes residue 44-243. ApoA-1 is synthesized 
as pre-pro-apoA-1 with 267 residues. The pre sequence is the signal sequence and the pro 
sequence is cleaved outside the cell by bone mophogenic protein (BMP) to form the 
A 1 f 243 . 'd [Franceschini G 1996] I h · · h A 1 · fi mature apo - o ammo ac1 s · . n t e mtestme, t e apo - 1s rrst 
secreted with the biggest lipoprotein particle chylomicrons (CM), but it is immediately 
transferred to HDL particles while the TG of CM is hydrolyzed by lipoprotein lipase. In 
the liver, hepatic apoA-1 is secreted lipid free/poor and becomes the apoprotein 
component of the nascent discoidal HDL via the action ofthe ABC-AI transporter. 
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1.2.2.2 ApoA-1 function 
1.2.2.2.1 Lipid binding 
As the major component of HDL, apoA-1 's fundamental function is its lipid binding. 
P · t d" f A 1 [Andrews et al. , 1976; McLacWan, 1977; Segrest et al.,l974] t d th t rev10us s u 1es o apo - sugges e a 
residues 44-243 encoded by exon 4 contain mainly putative amphiphathic lipid binding 
a-helices. As shown in [Figure 1.3], the putative helical assignment describes 10 
continuous tandem repeat helices (Hl-H10) in the exon 4 encoded region, which is 
punctuated mostly by prolines: H1 (44-65), H2 (66-87), H3 (88-98), H4 (99-120), H5 
(121-142), H6 (143-164), H7 (165-187), H8 (188-208), H9 (209-219), and HlO (220-
243). The last three helices of apoA-1 (helices 8-10, residue 185-243) are thought to play 
an essential role in lipid binding due to their lack of defmed structure in solution and high 
t t fh d h b. "d es [Brouillette, Anantharamaiah, eta!., 2001] con en o y rop o IC rest u . 
Exon 4 encoded 
Putative Helix Distribution 
1 ... Ui d2 l Hll I ! I 'f ~~~~~ H10 f }j, 
Figure 1.3 The helix distribution of apoA-1. 
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1.2.2.2.2 LCAT activation 
LCAT is an enzyme in the plasma, which is responsible for esterification of cholesterol 
to cholesterol ester in HDL. With the esterification process, the discoidal HDL is 
converted to a larger, spherical mature HDL particle. Lipid-poor apoA-1 is a good 
activator of LCA T. When the surface of the small lipid-poor HDL is largely covered by 
apoA-1 , LCAT interacts directly with apoA-1 [Sparks, Frank, et al , 1999l. Although the activation 
mechanism is not completely clear, deletion and point mutation experiments suggest that 
the H4 and H6 regions of apoA-1 are required for LACT activation [Sorci-Thornas et al., 1993• 
1997, 1998, Chroni eta!. , 2004, Roosbeek et al., 200 I] 
1.2.2.2.3 ABC-Al acceptor 
ABC-AI is called the gate-keeper of reverse cholesterol transport (RCT) pathway since 
it mediates the first step of the RCT pathway. ABC-AI belongs to the ABC transporter 
superfamily. ABC transporters are the trans-membrane proteins that use ATP as a source 
of energy to transport molecules across the plasma membrane, the intracellular 
membranes of the endoplasmic reticulum, peroxisome, and mitochondria [Dean, Hamon, et al.. 
2001 l. Tangier disease (TD) was discovered to result from the mutations in the ABC-AI 
gene [Rusts. et al., 1999l. TD is a rare genetic disorder and TD patients have a defect in efflux 
of cholesterol and phospholipids to apoA-1. Cross-linking experiments indicate that 
apoA-I is capable of specifically binding to ABC-AI and driving cholesterol efflux 
through the transporter [Silver, Tall ' 2001 l. 
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1.2.2.2.4 SR-Bl binding 
Scavenger receptor class B type 1 (SR-B1) is the HDL receptor mediating selective 
cholesterol uptake by the hepatic cell [Acton, Rigotti , eta!., 19961. SR-B1 is a glycoprotein with 
509 amino acids that belongs to the CD36 superfamily. It contains two trans-membrane 
domains and a large extracellular loop. Unlike the LDL receptor-mediated endocytosis, 
there is no endocytosis or degradation of lipoprotein involved for the cholesterol ester 
delivery from HDL to cells through SR-B 1. The HDL cholesterol uptake process is called 
"selective lipid uptake" (Krieger M, 19991. HDL binds to SR-B1 first, and then cholesterol ester 
of HDL diffuses into the plasma membrane or into the cell. The apoA-1 are recycled to 
be reutilized by the next reverse cholesterol transport. 
1.2.2.3 apoA-1 structure 
As illustrated in [Figure 1.3], apoA-1 contains 10 tandem putative amphipathic lipid-
binding a-helices. The C-terminal region of apoA-1 lacks defined structure with 
significant hydrophobic surface exposed to solution, which results in the self-association 
of apoA-1. Although apoA-1 has a poorly stabilized tertiary structure, its secondary 
structure has been explored extensively [Gorshkova et al. , 2000, 2002, 2006, Fang et al. , 2003, Zhu HL., 2004, 
2007, Mei X, Atkinson D, 2011] 
Site-directed mutagenesis has been used to study the structure and function of different 
domains of apoA-1 by making many point mutations and deletion mutations. 
Additionally, the structure and function of peptide fragments of apoA-1 have been 
studied to understand the role of the different sequence repeats. The peptide fragments 
represented either real sequence peptide analogs of apoA-1 or de novo-designed peptide 
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analogs of apoA-1. Studies of peptide analogs can reveal the lipid affinity, structural 
conformation and stability of the specific repeats or regions of apoA-l.[Nolte RT, Atkinson D , 
1992, Poulos G., 1994, Yang Chao, 2002) 
1.2.2.3.1 Secondary structure model 
Based on circular dichroism data and computer modeling, Nolte and Atkinson proposed 
a secondary structure model of apoA-1 as shown in [Figure 1.4] [Nolte and Atkinson, 19921. In 
this secondary structure model, the N-terminus (1-59) contains random coil or f3 
structure. The central region ( 60-184) mostly contains amphipathic a-helix. The C-
terminal (residues 185-243) contains two a-helical segments, residues 187-223 and 231-
243 . 
This secondary structure model has been further refined through mutation and deletion 
studies in the past years. The G 185 and G 186 residues were suggested to be located in a 
loop/disordered region by a double point mutation (G 185P, G 186P) experiment. [Gorshkova et 
al. , 2000l The apoA-1 region (136-143) was suggested to be unstructured in lipid-free apoA-
1 by deletion experiments. The segment 133-142 was confirmed as disordered by 
quadruple substitution (E125K/E128K/K133E/E139K) and lipid binding experiments 
[Gorshkova eta!., 20021 . The segment 123-130 was suggested to be helical through study ofthe 
<"1(121-142) deletion [Gorshkova et a!., 20061. The segment 131-143 was suggested to be 
disordered and function as a "hinge domain" . Also , C-/N-terminal truncation experiments 
suggested that the N- and C- termini are in close proximity in the lipid-free apoA-1 
conformation [Fang Y 'et a!. , 2003b]. Based on these extensive mutations, deletions and terminal 
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truncations studies, the secondary structure model was updated and refmed as in [Figure 
1.5] . 
231 
A 8 
242 
120 123 164 167 
COOH 
8 A 8 A B 
175 
A 8 A 
101 
Figure 1.4 The secondary structure model by sequence analysis. [Nolte and Atkinson, 19921 
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F225K 
!1(144 -165 ) 
._E139K 
!1(121-142 ) 
Figure 1.5 The secondary structure model of apoA-1 refined from mutation, 
deletion and terminal truncation studies. The point mutations are demonstrated in red, 
the deletion and trunctation are demonstrated in green. [Gorshkova et al. , 2000• 2002• 2006· Fang et al., 
2003, Zhu HL. , 2004, 2007] 
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1.2.2.3.2 X-ray structure of C-terminal truncated apoA-1 
The C-terminal domain of apoA-1 has been shown to be responsible for the initial lipid 
binding by point mutation and deletion mutation studies [Gorshkova et aL, 2000• 2002• 2006• Fang et aL, 
2003, Zhu HL., 2004, 2007, MCPhillips. et al, 2004, 2005, 2006, 2009] Th X t t f th b" t 
. e -ray s rue ure o e recom man 
human C-terminal deletion ~(185-243) apoA-1 was determined by Mei and Atkinson to 
2 2 A 1 t ·o [Mei X, Atkinson D. , 2011] . reso u 1 n . 
In this high-resolution structure, two lipid-free ~(185-243) apoA-1 molecules form an 
anti-parallel semicircular dirner. The diameter of this semicircular dimer is around 11 nrn, 
which is similar to the diameter of discoidal HDL [Figure 1.6]. The curvature of this 
semicircular dimer is induced by the proline residues located at the helical sequence 
junctions. There are two bundles at the ends of the apoA-1 dimer. Each bundle has three 
segments formed by residues 1-120 of one molecule and the fourth helix formed by the 
residues 143-184 of the other molecule. The segment bundles are mostly helical except 
L44-S55, which forms an extended structure. The segment bundles are stabilized by a 
cation-n interaction between K23 and W50 located on the extended structure. 
In [Figure 1.6] , the dimer structural elements are colored in accordance with the 
repeating A/B homology (colored as purple and cyan). The almost continuous helix is 
punctuated by the proline residues (labeled yellow). The dimer backbone has a perfect 
AB anti-parallel pairing within the continuous AB repeat region, especially the central 
region (121-142). 
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Proline 
Outside 
Central Segment Hinge 
Inside 
110 A 
Top view 
Figure 1.6 The overall structure of .6.(185-243) apoA-1 dimer by x-ray 
crystallography. PDB ID: 3R2P. Region (1-43) is green, consensus sequence A and B 
homology sequences are in purple and cyan. Proline residues are labeled in yellow [Mei x, 
Atkinson D., 2011) 
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1.2.3 Consensus sequence peptide models of exchangeable apolipoproteins 
The homology sequence AlB (A: PLAEELRARLR; B: AQLEELRERLG) was derived 
by Nolte and Atkinson based on the sequence analysis among most exchangeable 
apolipoproteins, such as apoA-1, apoA-4 and apoE [Nolte, Atkinson, 19921 . The most likely 
residue was chosen at each position based on the similar amino acid distribution pattern 
among the exchangeable apoliporoteins. Thus, consensus sequence repeats AlB, have 
similar residue type distribution to the apolipoproteins [Figure 1. 7]. If they are viewed on 
helical wheel, they can form "idealized" class A amphipathic helix [Figure 1.8]. 
Both repeat A and B exhibit high predicted helical propensities by sequence analysis. In 
ongoing studies, we constructed a consensus sequence peptide model, called CSP-ABAB 
(PLAEELRARLR AQLEELRERLG PLAEELRARLR AQLEELRERLG). The proline 
residues are located at the junction of the two AlB motives and thought to create a turn. 
This designed peptide is suggested to ideally model the AlB homology region of the 
exchangeable apolipoproteins. It's molecular and the conformational details concerning 
the inter/intra-helical interactions mimic the inter/intra-helical interactions of the AlB 
homology region of the exchangeable apolipoproteins. Therefore, CSP-ABAB peptide 
was chosen to further explore the conformational details of the apoA-1 and supplement 
the interactions details for both intra and inter-helical stabilization. [Mei x, Atkinson D., 2011 1 
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ApoA-1 
ApoA-IV 
Apo-E 
A B 
Figure 1.7 The consensus sequence homology A and B derived from the sequence 
analysis and amino acids distribution comparison among the exchangeable 
apoliporoteins apoA-1, apoA-IV and apoE. [Nolte, Atkinson, 19921 Similar amino acids 
distribution patterns are present among these apolipoproteins. Hydrophobic residues are 
colored yellow, polar residues are colored white, basic and acid residues are colo,;ed blue 
and red, respectively. 
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• basic • acidic 
Figure 1.8 Top view of space-filling model of the consensus sequence AB (Looking 
from N-terminal to C-terminal of the sequence). Hydrophobic residues are colored 
yellow, polar residues are colored white, negatively charged residues are colored red, and 
positively charged residues are colored blue. 
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1.3 Summary of previous contributions of the structural studies of CSP-ABAB 
Previous studies [Chao Y, 2003 ' Luo 0 ' 20091 of the consensus sequence peptide ABAB have 
suggested this peptide adopts a loose helix-turn-helix conformation. The proline residues 
sit at the beginning of the first helix and in the middle turn region. Unfortunately, 
although well diffracting crystals were obtained, trials to solve the crystal structure of 
synthetic CSP-ABAB were unsuccessful. [Chao Y. 20031 
The structural information obtained from the best model derived from the X-ray data 
suggests that its crystal packing is staggered four-helix bundles running along the b-axis 
(2 fold screw axis). Furthermore the molecular packing model also suggests that synthetic 
CSP-ABAB possibly adopts the helix-turn-helix conformation. [Chao Y, 20031 
Molecular dynamics simulation studies of the CSP-ABAB confirmed that CSP-ABAB 
folded to a helix-loop-helix overall conformation with the A and B helices aligned anti-
parallel (Luo 0 • 20091. Other than the hydrophobic inter-helical stabilization interaction, there 
is also a inter-helical salt-bridge network stablizing the anti-parallel comformation. But 
due to the limitation ofthe dynamic simulation method, the structure models obtained by 
dynamic simulation are not convincing enough. 
1.4 Aims and outline of this study 
Based on previous structural research on CSP-ABAB, we knew its major conformation 
in solution to be helix-turn-helix with the helix content as high as over 80% [Chao Y, 20031. 
However, specific details concerning the residues constituting each helix segment 
remained unknown. Also, the regions of the peptide that could exhibit multiple 
conformations when the CSP-ABAB peptide is unfolded remain unclear. What's more, all 
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the previous structural information of CSP-ABAB obtained was from the synthetic CSP-
ABAB, it is not clear whether the synthetic CSP-ABAB and the recombinant expressed 
CSP-ABAB always behave in the same way. To clarify the above questions, the 
molecular structural details about this peptide should be further examined. 
Some properties of this peptide, such as the limited size and the intrinsically degenerate 
sequence hindered the possibility of solving the molecular details of CSP-ABAB through 
the methods of crystallography. Instead, we undertook a nuclear magnetic resonance 
approach, which is superior to explore the structure of small peptides. To achieve these 
aims we needed to develop an expression system for the consensus sequence peptides, 
which would allow us to isotopically label the peptide and explore the peptide ' s structure 
in solution through the nuclear magnetic resonance method. 
Based on the previous structural studies ofthe CSP-ABAB, our hypothesis is that CSP-
ABAB will employ a two a-helix, anti-parallel hairpin conformation stabilized by 
hydrophobic interaction and hydrophilic interaction (such as salt bridges) as seen in the 
CSP-ABAB structure models determined by molecular dynamics [Luo D, 20091 and the 
apoA-I structure determined by X-ray crystallography [Mei x, Atkinson °· 2011 1. To test this 
hypothesis, we use NMR spectroscopy to solve the three-dimensional structure of CSP-
ABAB, and further analyze the structure features in detail. 
Firstly, we needed to construct a CSP-ABAB expression vector, express the CSP-
ABAB in an E. coli expression system and purify the target peptide. After the target 
peptide was purified and collected, we examined the secondary structure and stability of 
CSP-ABAB using a series of biophysical and biochemical methods, including HPLC, 
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mass spectrometry, circular dichroism, and NMR. Especially, NMR was used to explore 
the molecular details of this peptide through a series ofNMR experiments, including one-
dimensional, two-dimensional, and three-dimensional NMR experiments. 
After solving the three-dimensional solution structure of CSP-ABAB, the ideal aim is to 
further examine the stabilization interaction types for CSP-ABAB. These stabilization 
interaction details include the hydrophobic interaction and the electrostatic interaction 
(salt bridges). The results of this project enhanced our understanding of the molecular 
structural features of the consensus sequence peptide models of the exchangeable 
apolipoproteins, the stability and stabilization interactions details of apoA-1 and other 
exchangeable apolipoproteins. 
However, there are two big challenges before the start of this project. Firstly, due to the 
intrinsically degenerate sequence of these peptides, peak assignment in NMR is very 
challenging, which hinders the solution and refmement ofthe fmal molecular structure of 
the peptide. Secondly, due to the limited size and the solubility of these peptides, 
expressed peptides are very easily digested by proteases within the cells. A suitable 
expression system and purification strategy is extremely important for these special 
peptides and was successfully developed. 
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Chapter 2 Materials and Methods 
2.1 Materials 
General chemicals and materials 
General use chemicals were purchased from Sigma-Aldrich (St. Louis, MO). The 
molecular biology reagents were purchased from Invitrogen Life Technologies (Carlsbad, 
CA). Deuterated water (D20), [U- 13C] glucose and 15N-NH4Cl were obtained from 
Cambridge Isotope Laboratories (Andover, MA). Millipore Millex sterile syringe filters 
with 0.45 urn and 0.22 urn were obtained from Millipore (Billerica, MA), Spectra!Por 7 
dialysis tubing with a molecular weight cutoff (MWCO) of 1000 Daltons was obtained 
from Spectrum Laboratories (Rancho Dominguez, CA). 5 mm NMR sample tubes for 
500 MHz and 800 MHz magnetic fields were purchased from Shigemi. Inc. (Allison 
Park, PA). 
Plasmid and cells 
The stock ofE.coli DH5a strain with pTMHa plasmid was provided by Dr. Margaretha 
Carraway, Department of Physiology and Biophysics at Boston University School of 
Medicine. E.coli BL21 DE3 was purchased from New England Biolab (NEB, MA). Four 
primers used for the PCR cloning protocol, including two internal primers (ABAB-sense 
and ABAB-antisense) and two external primers (ABAB-HinDIII and ABAB-EcoRI) 
were purchased from Invitrogen life technologies (Grand Island, NY). 
Columns 
The Vydac 218 TP Cl8 column was purchased from Grace (Deerfield, IL). 
- 24-
Software 
XwinNMR 2.6 and Topspin 3.1 (Student Version) were purchased from Bruker 
(Billerica, MA). NMRPipe, NMRDraw and T ALOS+ [F. Delaglio, et aL, 19951 were from Dr. 
Frank Delaglio at the National Institute of Diabetes & Digestive & Kidney Diseases. 
CCPNMR was from the CCPN developing group at the department of biochemistry in 
Cambridge (Cambridge, UK). [Vranken WF, et aL, 2005] 
2.2 Circular dichroism (CD) spectroscopy 
2.2.1 Principles of circular dichroism 
Circular dichroism (CD) spectroscopy IS a methodology used to explore the 
conformational characteristics and thermal stability of proteins and peptides like CSP-
ABAB in aqueous solution. Theoretically, when plane-polarized (or in the case of CD, 
circularly polarized) light interacts with chiral molecules, such as biological 
macromolecules like proteins or DNA, the left and right circularly polarized light 
component, initially with the same amplitude, will be absorbed differentially. As a result, 
the left and right circular polarized light components then have different amplitudes and 
therefore the plane-polarized light is converted into elliptically polarized light. 
The ellipticity, 8, is defmed as the rotation angle 8 of the direction of light polarization. 
CD spectroscopy monitors the ellipticity [8] , as a function ofwavelength from 185 run to 
250 run (far-ultraviolet); or the ellipticity [8] from 250 run to 350 nm (near-ultraviolet) to 
explore the conformational characteristics of the sample. CD spectroscopic results are 
usually reported in degrees of ellipticity, and expressed as molar ellipticity [0]. 
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Molar ellipticity and molar CD is linearly related [Woody, 1996l: 
[9] = 32982 (EL -ER) [2.1] 
Here, ELand ER are molar extinction coefficients of left and right circularly polarized 
light. 
For proteins, the far-ultraviolet (far-UV) CD signal depends on the torsion angles phi 
and psi of the peptide bonds. Thus, the far-UV CD spectrum provides information on the 
protein secondary structure. The near-ultraviolet (near-UV) CD signal comes from the 
aromatic amino acid residues like Phe, Tyr, Trp and disulfide bonds. The near-UV CD 
signal is sensitive to the asymmetry of the packing ofthose groups and therefore provides 
. fi · h · (Woody 1996] m ormation on t e tertmry structure · . 
Far-UV CD spectra and secondary structure analysis 
Since CSP-ABAB has no aromatic residues, only the far-UV CD signal was recorded as 
the function ofwavelength from 185 nm to 250 nm. The measured ellipticity is reported 
as molar residue ellipticity [8]. The mean residue ellipticity (in deg cm2 dmor1) is 
determined from the observed CD signal as: 
[8] = 8obs·MW/(ncL) [2.2] 
[8] is mean residue ellipticity (in deg cm2 dmor1), 8obs is observed ellipticity (in mdeg), 
MW is molecular weight of the protein (in g/mol), c is protein concentration (in mg/mL), 
Lis the sample path length (in mm), and n is the number of the amino acids in the protein 
[Woody, 1996] 
- 26-
The far-UV CD signal depends on the peptide bond geometry (phi and psi angles), i.e. 
the protein secondary structure [Woody, 19961. Different secondary structures, such as a-
l. A h A d d "l h h t · · .c. UV t [Brahms and Brahms he tx, 1-'-s eet, 1-'-turn, an ran om cot ave c arac ensttc 1ar- spec ra · 
19801 [Figure 2.1]. a-Helix has a characteristic negative peak at 222 nm. The intensity of 
this peak is dominated by the contribution from an a helix and depends linearly upon the 
helical content, as expressed in equation 2.3. And the a-helical content is calculated by 
· · 2 3 [Woody 1996] usmg equat10n . . · 
a-helical percentage= (3000-[8222])/(36000+3000) = (3000-[8n2])/39000 [2.3] 
[Woody, 1996] 
Based on Formula [2.3] , the molar residue ellipticity at 222nm, [8222], is especially 
defined since there is no contribution from beta structures [Figure2.1 ]. The [8222] usually 
is used to estimate the protein helical content [Woody, 1996' Mao and Wallace, 19841. The percentage 
of a-helix content can be calculated from the far-UV CD signal at 222 nm. 
Far-UV CD provides a non-destructive way to explore protein secondary structure in 
dilute solution (1 0-500 ug/mL), and is especially reliable for highly helical proteins like 
apolipoproteins. However, there is a limitation to the conformational information derived 
from the CD experiments. The signal measured by CD only reflects an average over the 
molecular population within the sample. Thus, the results can not provide direct structural 
information for the protein CSP-ABAB or which specific amino acid residue is present in 
the a- helices. Thus, CD spectroscopy is a straightforward low-resolution method, 
which was used to determine the secondary structure of CSP-ABAB in solution, but 
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higher resolution structural studies from NMR are needed to provide more detailed 
conformational information. 
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Figure 2.1 Standard curves for a-helix, 13-sheet and random coil from four peptides. 
Each peptide only has one type ofthe secondary structures. [BrahmsandBrahms, 1980] 
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Thermal unfolding and assessment of protein stability 
Theoretically, protein unfolding is assumed to be a thermodynamically reversible 
equilibrium process between two states in dilute solution, including lipid-free 
I. t · [Gursky 0 , Atkinson D. , 1996] apo 1popro ems . 
For a reversible thermodynamic transition, 
~G = ~H- T~S. [2.4] 
in which ~H = Hu-HF, is defmed as the effective (Van 't Hoffs) enthalpy of unfolding, 
and is the difference between the enthalpy of the unfolded (U) and folded (F) protein 
states. ~G is the Gibbs free energy difference. ~Sis the difference between the entropy of 
the unfolded and folded protein. 
According to the Gibbs distribution, the protein thermodynamic stability is related to the 
equilibrium constant l<eq = [U]/[F] as ~G(T) = Gu-GF = RTlnl<eq(T) = RTln([U]/[F]). The 
midpoint of the protein unfolding transition, T m, and Keq can be determined from the 
thermal unfolding curve acquired by CD [Bae and Sturtevant, 1995l . Thus the unfolding curves 
can indicate whether the protein is thermostable. 
Measurement of the CD signal at fixed wavelength, 222 nm, for a protein or peptide as a 
function the temperature or concentration of chemical denaturant can provide information 
on its conformational stability. The far-UV CD spectrum indicates the secondary 
structure of CSP-ABAB in solution is a.-helical and the characteristic wavelength for ex.-
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helix is 222 run, in this work the ellipticity of the protein at fixed wavelength 222 nm was 
monitored as the temperature changed from 1 'C to 96 'C and back to 1 'C. 
2.2.2 Sample preparation 
In the CD experiments described here, 5 mM phosphate buffer at pH 7.4 was generally 
used. 5 mM Phosphate buffer (PB) was made by combining NaH2P04 and Na2HP04 and 
the pH was modified to 7.4. Lyophilized CSP-ABAB peptide powder was dissolved in 
filter sterilized phosphate buffer to make a stock protein solution. The concentrations 
were determined by amino acid analysis, which is the most accurate method for 
determining the concentration of this type of peptide without any aromatic residues. The 
concentrations of peptides were then diluted to range from 0.005 mg/mL to 0.5 mg/mL. 
Far-UV CD spectra were recorded using an AVIV 62 DS Circular Dichroism 
spectropolarimeter with thermoelectric temperature controller (AVIV Instruments, Inc, 
Lakewood, NJ). 1-2 mm path-length quartz cells were used. The CD spectra were 
recorded from 185 nm to 250 nm at 25 'C with a 1 nm step size, 30 seconds accumulation 
time per data point, and averaged over three consecutive scans. The thermal unfolding 
curves were recorded at 222 nm from 1 'C to 96 'C, with a 1 'C step size, 70 seconds 
accumulation time per data point. 
2.2.3 Data collection and analysis 
All of the data sets were processed with MicroCal Origin version 7.5 (MicroCal 
Software, Inc, Northampton, MA). The buffer baseline scans were averaged and 
subtracted from each scan for the same group of data sets. The scans were converted into 
mean residue ellipticity [E>] using formula 2.2. The helical content was determined based 
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on the formula 2.3. The percent helical content and standard deviations were plotted with 
MicroCal Orgin software. 
2.3 Nuclear Magnetic Resonance Spectroscopy (NMR) 
2.3.1 Theoretical background ofNMR 
Nuclear magnetic resonance (NMR) spectroscopy is a technique that exploits the 
magnetic resonance properties of certain nuclei. NMR spectroscopy can provide 
information about the structure and dynamics of proteins. The protein NMR field was 
pioneered by Richard R. Ernst and Kurt Wiithrich[Wothrich K, 19901. Usually, structure 
determination by NMR spectroscopy consists of several phases; sample preparation, 
resonance assignment, restraints generation, calculation and validation of a structure. 
Each NMR spectrum contains more than one peak. The position of each peak ts 
described as chemical shift (8), which represents the effect of the chemical environment 
on each nucleus, i.e. the effect of the magnetic field of adjacent nuclei both chemically 
bonded and in proximity to each nucleus. Chemical shift is defined in terms of frequency 
in Hz (ro) and a reference frequency (roo) in parts per million (ppm) as in equation [2.5].[ 
WOthrich K, 19861 Chemical shift is independent of Bo (denoting the strength of the externally 
applied magnetic field) , thus the NMR experimental data from different spectrometers 
can be compared. 
[The unit is in parts per million (ppm)] [2.5] 
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The one dimensional (ID) NMR spectrum of a protein usually is very crowded with 
overlapping peaks and unusable for direct spectral analysis. Two dimensional (2D) NMR 
data provide information about the relationship between atoms. The cross peaks shown in 
the 2D NMR spectra indicate specific interactions between those atoms depending on the 
• 1'. d [Wuthrich K 1986] type ofNMR expenment per1orme . · 
NOESY (Nuclear Overhauser Effect Spectroscopy) and TOCSY (TOtal Correlation 
SpectroscopY) spectra are two common 2D proton spectra. The cross peaks observed in 
these spectra are between the proton resonances. A TOCSY experiment gives information 
about through bond interactions but at odd intervals (i.e. 1 bond away, 3 bonds away, 5, 7 
bonds away, etc.). The interacting atoms are within the same spin system. A NOESY 
experiment gives information about through space interactions between atoms with a 
distance of less than ~5 angstrom apart. The information can be used to locate atoms 
within three-dimensional space and is used to determine the protein or peptide structure. 
The 2D HSQC (Heteronuclear Single Quantum Coherence) experiment correlates 
chemical shifts of directly bound nuclei (i.e. two types of chemical nuclei). For example 
1H-, 15N-HSQC correlates chemical shifts within NH groups. Here, 1H-, 15N-HSQC and 
1H-, 13C-HSQC are most commonly used 2D NMR spectroscopy experiments. 
In 15N-HSQC, each amino acid residue within the peptide has a NH group except the 
first residue and the proline residues, which should have a unique peak in the peptide's 
spectrum. The number of peaks in the spectrum should match the number of residues in 
the protein (any side chains with nitrogen-bound protons will add additional peaks). 15N-
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HSQC is the most standard experiment and shows all H-N correlations. This spectrum is 
a fmgerprint of a protein/peptide. The 1H-15N-HSQC spectrum's resolution can be used to 
decide whether to further 13C label the sample and run the 3D NMR experiments with it. 
1H-13C-HSQC is the carbon equivalent ofthe 1H- 15N-HSQC. All H-C correlations are 
shown in the spectrum. It is the basis for the side chain assignment by 3D 13C 
experiments. 1H-15N-HSQC and 1H-13C-HSQC, these two experiments theoretically 
contain all the backbone N-H correlations and C-H correlations, and therefore become 
the basis of most 3D spectral analysis. 
To run the above types of NMR experiments on the CSP-ABAB, the recombinant 
expressed protein need be 15N and 13C isotopically labeled and then be purified. 
2.3.2 Sample Preparation 
The purified CSP-ABAB peptide was lyophilized and stored at -80 ·c for the later 
. structure determination NMR experiments. The sample solution was prepared by 
combining 2 mM CSP-ABAB lyophilized powder, 10% D20 (Deuterium oxide), 20 mM 
NaH2P04, 0.05% NaN3, and 10 nM TMSP (trimethylsilyl propanoate was used as internal 
reference) in D20 to a fmal volume of 550 ul. The pH was adjusted to the desired value 
with HCl and NaOH during the sample solution preparation. Then, 450 ul of the prepared 
sample was transferred into the 5 mm Shigemi tube for the NMR experiments. 
2.3.3 NMR Data Collection and processing 
Usually, a certain series of NMR experiments are necessary to determine the protein 
solution structure. As discussed, these include 2D 1H- 1H correlation spectroscopy 
(COSY), total correlation spectroscopy (TOCSY), nuclear Overhauser effect 
- 33-
spectroscopy (NOESY), 1H- 15N Heteronuclear single-quantum coherence (HSQC), 3D 
1H-15N TOCSY-HSQC, and 3D 1H-15N NOESY-HSQC. Unlabeled, 15N-labeled and 13C-, 
15N- doubly labeled CSP-ABAB samples were prepared at different pH. The preliminary 
lD and 2D NMR experiments were performed at different temperatures on a Bruker 
A vance DMX 500 MHz. A 5 mm inverse-detection, triple-resonance probe was used for 
detection of 1 H nuclei, a 10 mm broadband resonance probe was used for detection of 13C 
nuclei. All samples were placed in 5 mm Shigemi tube with 10% D20 added to provide 
an internal lock. 3D NMR experiments were performed on a Bruker AV ANCE 800 MHz 
spectrometer (Brandeis University, MA) with a 5 mm TCl cryoprobe with higher 
sensitivity and resolution for the later assignment. 
1D NMR data on CSP-ABAB were collected at the 1H resonance frequency using the 
program 'p3919gp ' which suppresses water signal using the WATERGATE technique 
[Piotto et al, 1992; Sklenar et al, 1993l 1H-15N HSQC spectra were obtained with 256 tl increments 
and 2048 t2 data points for the same sample solution at pH 5, 5.5 and 6 at 293K. The pH 
5.5 was chosen for the following NMR experiments. 1 H- 1~ HSQC spectra were obtained 
with 256 tl increments and 2048 t2 data points for the same sample solution with pH 5.5 
at 283K, 288K, 293K, 298K, and 303K. The temperature 293K was chosen as the 
working temperature for the later NMR experiments. All the subsequent NMR 
experiments were performed with the sample solution at pH 5.5 and at 293K. 
2D 1H-1H TOCSY data were recorded using the pulse program 'mlevgptpl9' with the 
technique of time-proportional phase incrementation (TPPI) [Marion and Wuthrich, 1983; Redfield and 
Kunz, 19751 and WATERGATE at 500 MHz. 2D 1H-1H NOESY data were recorded using 
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the standard pulse sequence ' noesygptp19 ' with 512 t1 increments and 2048 t2 data 
points on 500 MHz spectrometer. The mixing time was 200 ms. 
The following spectra were all recorded on 800 MHz spectrometer. 2D 1H- 15N HSQC 
spectra were recorded using the pulse program "hsqcetf3gpsi" with 256 t1 increments and 
2048 t2 data points. 2D 1H-13C HSQC spectra were recorded using the pulse program 
"hsqcetgpsisp" with 256 t1 increments and 4096 t2 data points. The 3D HNCA spectra 
were recorded using the standard Bruker pulse program "hncagp3d" with 128, 40 and 
2048 data points for t1 (13C), t2 C5N) and t3 (1H), respectively. The 3D HNcoCA spectra 
were recorded using the standard Bruker pulse program "hncocagp3d" with the same t1, 
t2 and t3 data points as the HNCA. The 3D HNCACB spectra were recorded using the 
standard Bruker pulse program "hncacbgp3d" with the same t1 , t2 and t3 data points as 
the HNCA and HNcoCA. The 3D HCCH-TOCSY spectra was recorded with the pulse 
program "hcchdigp3d" with 128, 64 and 2048 data points for t1 CH), t2 (13C) and t3 (1H), 
respectively. The 3D NOESY-HSQC spectra were obtained with 128, 64 and 2048 data 
points for t 1 eH), t2 (15N), and t3 (1H), respectively. The spinlock time for TOCSY-type 
experiments was set to 80 ms. The mixing time for NOESY-type experiments was 150 
ms. 
The data obtained were processed with nmrPIPE [F. Delaglio, et a! , 19951, Topspin 3.1 (Bruker, 
Billerica, MA) and CCPNMR 2.2 [Vranken WF, et aL, 2005l. The spectra were displayed and 
chemical shifts were assigned with CCPNMR 2.2 [Vranken WF, et aL, 20051. The structure 
calculation was run by ARIA 2.3 [Rieping w ' et aL, 20071. The structure analysis was run by 
CCPNMR 2.2 and Procheck [Laskowski et aL, 19931. 
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2.4 The expression and purification system of consensus sequence peptide CSP-
ABAB 
In general terms, the amplified ABAB sequence (132 base-pair fragment) from PCR 
was ligated into a phagemid-T7 expression vector pTMHa 30-51. The expressed 
recombinant protein contained a TrpLE leader sequence, followed by a methionine 
residue and then the target ABAB sequence, three stop codons and extra terminal bases. 
The 5' and 3' restriction sites were HinDIII and EcoRI respectively [Figure 2.2]. The 
plasmid produces a fusion protein which is expressed into inclusion bodies in the cell. 
Therefore the target ABAB peptide is protected from degradation in the inclusion body. 
Cyanogen bromide (CNBr) was used to cleave at the methionine residue site thus 
releasing the target ABAB peptide. The expressed target peptide was separated from the 
aqueous insoluble TrpLE protein and fmally purified. The flowchart of the recombinant 
CSP-ABAB expression and purification is illustrated in [Figure 2.3]. 
2.4.1 Construction of CSP-ABAB expression vector 
Four primers were used for the PCR cloning protocol, including two internal primers 
(ABAB-sense and ABAB-antisense) and two external primers (ABAB-HinDIII and 
ABAB-EcoRI) with the sequence shown in [Figure 2.4]. The primers were purified by 
the supplier (Invitrogen, NY) and then diluted in diethylpyrocarbonate (DEPC)-water to a 
concentration of 0.5 nM/ul for the ABAB-sense and ABAB-antisense, and 30 nM/ul for 
the ABAB-HinDIII and ABAB-EcoRI for later use. 
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Construct the ABAB expression vector 
lnclusi.on body preparation 
Cloning & 
Expression 
Cyanogen Bromide 
Cleave ABAB from TrpLE 
n HPLC 
Figure 2.2. CSP-ABAB expression and purification strategy. 
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Figure 2.3 Insert and vector used for CSP-ABAB expression. 
- 38-
Stops 
Kanamycin 
Resistance Gene 
Primer Name DNA Sequence 
GCAAGACTICGTGCGCAACTIGAAGAGTIACGA 
ABAB - sense GAACGTCTAGGAGCGCA 
TAGTICCTCGGCCAACGGTCCAAGCCTCTCTCTG 
ABAB - antisense • AGTICCTCCMCTGCG 
ABAB - HinDIII 
ABAB- EcoRI 
CGCGCTAAGCTIATGCCACTAGCAGAAGAGTIG 
CGAGCMGACTICGTGC 
GAGCTCGAATICTCACTATIATCTIAACCGCGCT 
CTIAGTICCTCGGCCA 
Figure 2.4 DNA sequences of primers used for CSP-ABAB expression. 
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The adapter from the PCR was formed by annealing the two internal primers, ARAB-
sense and ABAB-antisense. 1 ul lOX annealing buffer (0.1 M TRIS, 0.5 M NaCl, 0.1 M 
EDTA, pH 7.4), 5 ul DEPC-water, and 2 ul (0.1 nM) ABAB-sense and ABAB-antisense 
primers were combined together to form the annealing mixture. Annealing was carried 
out in a PTC-200 Peltier thermal cycler (MJ Research, Inc, Waltham, MA). The program 
was as follows : 
1. 1 00 'C for 2 minutes 
2. 65 'C for 10 minutes 
3. 64.5 OC for 1 minute 
-0.5 OC per cycle 
4. Go to #3 88 times (to 21 'C) 
5. 4 OC forever 
6. END 
After the adapter (corresponding to ABAB) was annealed, it was amplified with the two 
external primers, ABAB-HinDIII and ABAB-EcoRI by PCR. 3 ul of the annealed 
adapter, 5 ullOX PCR buffer (200 mM Tris-HCl, 500 mM KCl, pH 7.4), 2 ul MgS04, 1 
ul dNTPs, 1 ul Taq polymerase, 34 ul DEPC-water and 2 ul each of the ABAB-HinDIII 
and ABAB-EcoRI primers were combined and the mixture then was placed in a PTC-200 
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Peltier thermal cycler. The program ran as follows, The annealing temperature was chosen 
as 56 ·c based on the base pair composition of the two external primers. 
1, 94 ·c for 2 minutes (denaturation) 
2, 94 ·c for 45 seconds (denaturation) 
3, 56 ·c for 45 seconds (annealing) 
4, 68 ·c for 30 seconds (extension) 
5, go to #2 29 times 
6, 68 ·c for 3 minutes (extension) 
7, 4 ·c forever 
8,END 
The PCR fragment and the expression vector needed to be digested to expose the proper 
base-pair sequences for ligation of the insert to the backbone. The restriction enzyme 
digestion mixture for the insert was composed of 8 ul DNA, 2 ul lOX reaction buffer (50 
mM Tris-HCI, 10 mM MgCl2, 50 mM NaCI, pH 8.0), 1 ul each ofEcoRI and HinDIII, 
and 8 ul water. The restriction enzyme digestion mixture for the backbone was composed 
of 10 ul DNA, 2 ul lOX reaction buffer, 1 ul each ofEcoRI and HinDIII, and 6 ul water. 
The restriction enzyme digestion mixtures were incubated at 37 'C for 1.5 hours. After 
digestion, the DNA fragments were run on a 1.5% TAE (Tris-acetate-EDTA) agarose gel 
with 0.005% ethidium bromide to be separated. The DNA fragments were cut from the 
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gel and the DNA was extracted using the Matrix Gel Extraction Protocol (QIAGEN Inc, 
Valencia, CA). The collected DNA fragments ' yield and purity was checked again by 
rerunning on a 1.5% T AE agarose gel with 0.005% Ethidium Bromide. 
2.4.2 Ligation 
The PCR fragment and the expression vector need to be ligated. The ratio of the insert 
to backbone was determined based on the following Formula [2.6] [Sambrook eta! ., 19891. 
Amount insert needed (ng) = 
[(size of insert in basepairs) X(ng backbone)]/(size of backbone in basepairs) 
After the PCR products were digested with the two enzymes, HinDIII and EcoRI as 
described above, they were ligated with the expression vector based on their basepair 
ratio. The ligated product was transformed into the DH5a E.coli. After the colonies 
appeared, they were picked and inoculated into 5 ml LB media with 50 ).lg/ml kanamycin 
at 37 'C for overnight incubation. The DNA was collected from the incubated cell culture 
using a Qiagen Miniprep Plasmid Extraction Kit. The extracted plasmids were sent to the 
Tufts University Core Facility for DNA sequencing and the sequence was confirmed. 
Plasmids were stored at -20 'C for later use. 
2.4.3 Transformation and expression 
Once the expression plasmid was constructed successfully, it was transformed into the 
E.coli BL21 DE3 cells. The concentration of the stock plasmid was 39.9 ng/ul. 2ul stock 
plasmid was diluted 10 fold to 20 ul with concentration of 3.89 ng/ul. 50 ul competent 
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cells (BL21 DE3) were thawed on wet ice for about 10 minutes. 20 ul diluted plasmid 
was gently mixed together with 50 ul competent cells and incubate on ice for 30 minutes. 
The mixture was heat shocked at 42 OC for exactly 20 sec, incubated on ice for 5 more 
minutes and then 950 ul LB media was added. Cells were rotated at 37 OC for 1 hour. 
After brief centrifugation, the cells pellets were resuspended in LB and spread on 
LB/kanamycin (50 ug/mL) plates and incubated overnight at 37 OC. The next day, a 
single colony was picked from the plates and inoculated into 10 ml LB/kanamycin. After 
growing overnight, the cell culture was diluted into 1 L LB/kanamycin medium at 37 OC. 
Protein expression was induced by addition of 1 mM IPTG when the cells reached an 
OD60o of0.6 ~ 1.0. The cells were harvested by centrifugation 4 hours after induction. 
Expression of 15N-labeled CSP-ABAB 
The transformation protocol was the same for the 15N-labeled CSP-ABAB as for the 
unlabeled CSP-ABAB. The 15N-labeled CSP-ABAB was expressed using a similar 
protocol as for the unlabeled CSP-ABAB except that LB medium was replaced with M9 
media, in which 15NH4Cl e5N, 99%] was used as the only nitrogen source once the cell 
were ready to induce. After the dilution of cell culture into 1L M9/kanamyicin medium 
[Marley, et aL, 2001l, transformed E. coli cells were grown at 37 OC until OD6oo reached 0.6 ~ 
1.0. Cell pellets in 2 L LB medium were combined and transferred to 1 L 15N-Labeled 
M9 media. Cells were grown for another 1 hr before induction with 1 mM IPTG. The 
cells were harvested by centrifugation 4 hours after induction. 
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Expression of 13C and 15N-labeled CSP-ABAB 
Double labeled CSP-ABAB was expressed using a similar protocol as for the 15N-
labeled CSP-ABAB except that the M9 medium was slightly modified in which the 
15NH4Cl [15N, 99%] and [U- 13C] glucose were used as the only nitrogen source and 
carbon source respectively. The induction and collection procedures were as described. 
[Marley, et. al., 2001] 
2.4.4 Inclusion body preparation, cleavage and purification 
After expression, the recombinant protein contained the fusion protein TrpLE. The 
expressed recombinant protein formed inclusion bodies within the cells, which protected 
the target peptide from degradation. Thus, the target recombinant ABAB peptide needed 
to be isolated from the inclusion bodies. CNBr was used to cleave at the Met residue site 
between the TrpLE and ABAB sequence to release the ABAB peptide from the TrpLE. 
First, the cellular pellet was solubilized in 18 ml water, 400 ull M TRJS pH 7.5, 100 ul 
1M MgCh, and 20 ul 1 mg/ml DNase 1 and the mixture was left to sit on bench for 5 to 
10 minutes. The mixture was sonicated to homogeneity. When the mixture in the tube 
was homogenized, the mixture was centrifuged at 11180 x g for 30 minutes at 4 ·c and 
the supernatant was decanted. Second, the pellet was resuspended in 20 ml buffer which 
contained 20 mM TRIS pH 7.5, 1% Triton X-100, 1% deoxycholic acid, and 1 mM 
EDTA. The mixture was vortexed and sonicated until it was homogenized. The mixture 
was centrifuged at 11180 x g or 30 minutes at 4 'C and the supernatant was decanted 
again. Thirdly, the pellet was re-suspended in 10 ml buffer which contained 20 mM TRJS 
pH 7.5, 6 M Guanidine and 1 mM DTT. The mixture was vortexed and sonicated until it 
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was homogenized and transferred to a 250 ml centrifuge bottle. 90 ml ddH20 was then 
added to the mixture to precipitate the recombinant protein and the mixture was 
centrifuged at 11180 x g for 30 minutes. The supernatant was decanted again and the 
pellet was saved for the CNBr cleavage procedure. 
The pellet, purified after the inclusion body preparation procedure, was resuspended in 
10 ml 70% formic acid. The solubilized mixture was transferred into a rotovap flask. 10 
ml 5 M CNBr in acetonitrile was added into the flask and the flask was wrapped with 
aluminum foil and incubated with a gently spinning stir-bar for 4 hours. The resultant 
sample was transferred into 1000 MW cutoff dialysis tubing and dialyzed against 1 L 
ddH20 for 36 hours with 3 changes of buffer at room temperature. All these steps were 
carried in a chemical fume hood due to the toxic nature of the CNBr. After dialysis, the 
sample was removed from the hood and spun at 1789 x g for 10 minutes. The pellet and 
supernatant that contained the ABAB peptide, were saved separately. 
To check whether the cleavage was complete, samples of the pellet and supernatant 
were run on 16.5% tricine gels at 100 V for 1 hour. After confirmation of adequate 
cleavage of the target peptide from the fusion protein, the collected supernatant was run 
on the high-performance liquid chromatography (HPLC) to refine the purity. 
2.4.5 High performance liquid chromatography 
High performance liquid chromatography (or high pressure liquid chromatography, 
HPLC) is a technique that utilizes the different hydrophobicity of the compounds to 
separate a mixture of compounds. A pump provides the high pressure to move the mobile 
phase and analyte through the densely packed column and a UV detector shows a 
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characteristic retention time for the analyte. Analyte retention time varies depending on 
the strength of its hydrophobic interactions with the stationary phase, dependent on the 
composition of solvent used, and the flow rate of the mobile phase. Considering that the 
CSP-ABAB's molecular weight is around 5 K.Da, the VYDAC 218 TP C18 reversed 
phase column was used for the peak separation. 
HPLC profile showed two major peaks shown that were very close to each other 
[Figure 3.6]. The two major peaks were collected separately and were futher analyzed, 
which was described in details in Chapter 3. The resultant collected peak samples were 
evaporated to remove solvents. The peptide sample was lyophilized and stored at -80 ·c . 
2.4.6 Mass spectrometry 
The identity of the purified ABAB peptide was confirmed by matrix-assisted laser 
desorption/ionization (MALDI) mass spectral analysis performed at the molecular 
biology core facilities of the Dana Farber Cancer Institute, Boston, MA. 
2.4. 7 Amino acid analysis 
Amino acid analysis is a method to determine the amino acid composition of a protein 
or peptide. It is independent on the aromatic residues of the protein. The experimental 
procedure usually contains two steps. The first step is to hydrolyze the protein into its 
individual amino acid constituents. The second step is to measure the relative quantity of 
each kind of hydrolyzed amino acid. Based on the quantified chromatography results of 
amino acid analysis, the identity and composition ofprotein or peptide can be determined 
or confirmed if the sequence is known. The amino acid analysis experiments on the 
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purified CSP-ABAB were performed in the molecular biology core facilities of Dana-
Farber Cancer Institute, Boston, MA. 
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Chapter 3 Expression and purification of recombinant CSP-ABAB 
The expression and purification of CSP-ABAB was known from prior studies [Wally J.L. , 
20001 to be difficult because ofthe small size ofthe CSP-ABAB peptide and its propensity 
to degrade. In these studies we avoided the degradation problem by protecting the 
expressed recombinant peptide fused to TrpLE in insoluble inclusion bodies. This chapter 
describes the expression system and purification method for the unlabeled, 15N-labeled, 
and 13C, 15N-labeled CSP-ABAB. 
3.1 Expression of recombinant CSP-ABAB 
3.1.1 Construction the CSP-ABAB plasmid 
The CSP-ABAB adapter was created firstly by annealing the internal ABAB-sense and 
ABAB-antisense primers, and the adapter was then amplified through a PCR reaction 
together with ABAB-HinDIII and ABAB-EcoRI primers. The resultant PCR fragment 
and the expression vector were enzyme digested with HinDIII and EcoRI. Before being 
ligated together, the double digested ABAB insert segments were visualized on a 1.8% 
T AE agarose gel under UV light as shown in [Figure 3.1]. The double digested pTMHa 
backbone were visualized on a 0.8 % T AE agarose gel under UV light as shown in 
[Figure 3.2]. Both the double digested insert and backbone were excised from the 
agarose gel and purified. The purified insert and backbone DNA were rerun on another 
1.5% T AE agarose gel to confirm the purity. The purity confirmed insert and backbone 
were ligated together and transformed into the cell line DH5a E. coli. The transformed 
cells were then spread on LB plates containing kanamycin and incubated at 37 ·c 
overnight. 
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766bp 
350 bp 
300bp 
250 bp 
200 bp 
150 bp 
Figure 3.1 1.8% TAE agarose gel showing the insert ( cut ABAB) after double 
digestion by restrictions enzymes HinDIII and EcoRI. M is the low molecular weight 
DNA ladder. 
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8Kb 
6Kb 
SKb 
3Kb 
2Kb 
1Kb 
Figure 3.2 0.8% T AE agarose gel showing the backbone (pTMHa) before and after 
double digestion by restrictions enzymes HinDIII and EcoRI. Ml is the lkb DNA 
ladder. 
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Figure 3.3 DNA sequence of the E.coli clone containing the correct ABAB insert 
DNA sequence including the HinDill site, methionine, the ABAB insert sequence, 
three stop codons and the EcoRI site. 
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Single colonies were picked from the LB plates and inoculated into 15 ml LB media 
containing kanamycin, incubated at 37 ·c overnight and the plasmid DNA was extracted. 
The transformation was performed using the purified plasmid DNA and the competent 
cells. After the transformation and heat shock, the cells were spread over LB plates 
containing 50 ug/ml kanamycin and incubated at 37 ·c overnight. The single colonies 
were picked from the LB plate and cultured in 15 ml LB media with kanamycin. The 
culture was then spread on an LB plate with kanamycin at 37 ·c overnight. Another 
single colony was picked from the LB plate and the inoculation was followed. Three 
cycles of the above steps were run to assure only a single clone was present on the LB 
plate at last. The DNA ofthese colonies was collected and sent to the Tufts core facility 
to be sequenced. Three of four sequenced colonies were identified as having the ABAB 
sequence As shown in [Figure 3.3] the identified colony was used in a small scale culture 
and the cells were collected after four hours. The plasmid DNA was collected, its 
concentration was measured as 38.9 ng/mL and the DNA was stored at -20 ·c for future 
use. 
3.1.2 Optimization of the expression cell line and the IPTG induction time 
To choose the optimal expression cell line for the recombinant protein, small-scale 
expression assays were run on two cell lines: BL21 DE3 and BL21 plys S. Both of the 
transformations and expression were performed with the same protocol as described in 
the Chapter 2. The pellets of all the cell samples were collected at different induction 
times for the two cell lines, lysed and run on a 16.5% tricine gel for 1 hour at lOOV. The 
band at around 15 kDa is where the expected recombinant protein should be present. The 
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cell line BL21 DE3 showed better expression results for the recombinant protein. 
Therefore, the cell line BL21 DE3 was chosen as the expression cell line for the large 
scale expression for CSP-ABAB peptide. Similar small-scale expression assays were run 
to find the best induction time and 4 hours was chosen as the optimal induction time 
based on the small scale peptide expression level checked on the tricine gels. 
3.1.3 Recombinant protein large scale expression in E. coli cells with IPTG 
induction 
Unlabeled recombinant protein expression 
The large scale expression was carried out with the cell line BL21 DE3. The optimal 
expression conditions based on the small scale expression results were used for the 
protein expression. After induction, the cells were grown for another 4h at 37 ·c, and 
then harvested by centrifugation. The cell pellet was stored at -80 ·c for future 
procedures. 
15N labeled recombinant protein expression 
Similar to the unlabeled CSP-ABAB expression, we transformed the plasmid into the 
BL21 DE3 cell line. Freshly transformed cells were grown to mid-log phase when the 
OD was between 0.6 to 1.0. Four liter cell cultures were combined into one liter M9 
minimal media with 15N-ammonium chloride and glucose. Protein expression was 
induced by addition of 1 mM IPTG after 1 hour incubation at 37 ·c. After growth for 
another 4h at 37 ·c, cells were harvested by centrifugation. The pellet was stored at -80 
·c for future procedures, which is the same as the unlabeled protein expression. 
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13C and 15N labeled recombinant protein expression 
For the double labeled recombinant protein expression, the plasmid was again 
transformed into the BL21 DE3 cell line. Freshly transformed cells were grown to mid-
log phase. Similar to the single labeling, four liter cell cultures were combined into one 
liter M9 minimal media with 15N-ammonium chloride and 13C-glucose. Protein 
expression was induced by addition of 1 mM IPTG after 1 hour incubation at 37 ·c . After 
growth for another 4 hours at 37 ·c, cells were harvested by centrifugation. The cell 
pellets were stored. The following purification and confirmation procedure are the same 
as preVIOUS. 
3.2 Purification of recombinant CSP-ABAB 
Figure 3.4 shows the tricine gel results of unlabeled recombinant protein expression. The 
single label or double label expression showed similar tricine gel results. The third lane 
(4 hours lane) shows that the expected recombinant fusion protein (15KDa) was over 
expressed after 4 hours IPTG induction. The fourth lane, i.e. the IB lane, was mainly 
inclusion bodies. Compared to the third lane, multiple unexpected proteins were removed 
through the inclusion body preparation step. 
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Marker Before 4 how·s m 
l5KDa 
Figure 3.4 Tricine gel electrophoresis of recombinant protein expression. 
The 'marker' lane is the broad-range protein marker. Highlighted band area is 15KDa. 
'Before' lane is the cell pallets collected before IPTG induction, '4' lane is the cell pallets 
collected 4 hours after IPTG induction. ' IB' is the inclusion bodies after the purification. 
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The CNBr cleavage efficiency was checked by using the tricine gel electrophoresis. 2 
hours CNBr cleavage results after inclusion bodies preparation step is shown in 
[Figure3.5]. The major band is at a 15KDa position. After the inclusion body 
preparation, the resultant pellet was re-suspended and solubilized in 10 ml 70% formic 
acid. The sample was transferred into a rotovap flask wrapped with aluminum foil. Three 
heaping scoops of CNBr were added into the flask and the flask was incubated in the dark 
with a gently spinning stirbar for two hours. Two hours later the resultant sample was 
placed in 1000 MW cutoff dialysis tubing and dialyzed against 1 liter PB buffer for 48 
hours. The buffer was changed 3 times during the dialysis. The buffer pH was confirmed 
to be neutral after the dialysis. 
The sample was transferred from the dialysis tube to a centrifuge tube and spun at 4000 
rpm for 20 minutes. The pellet and supernatants were saved and run on a tricine gel to 
check the CNBr cleavage results. The cell pellet lane contained the mixture of the 
uncleaved inclusion bodies (15KDa) and the cleaved TrpLE fusion protein (lOKDa). The 
supernatant lane contained only one major band which was below 6.5KDa. To 
completely cleave the recombinant proteins and increase the yield of the target peptides, 
the CNBr cleavage time was set to 4 hours. 
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lSKDa 
cell pallets 
2h CNBr clea:va 
lSKDa 
1:2KDa 
6.5 KDa 
Figure 3.5 Tricine gel of recombinant protein upon cleavage and purification. The 
marker lane is the broadrange protein marker. 15KDa, 12KDa, 6.5KDa positions are 
labeled. 'IB ' lane is the prepared inclusion bodies. Cell pallets and supernatants are on 
the 2nd and 3 rd lane after the CNBr cleavage. The 2 nd lane contains the mixture of the 
uncleaved inclusion bodies (15KDa) and the cleaved TrpLE fusion protein (lOKDa). 
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High-performance liquid chromatography (HPLC) 
After confirmation of almost complete cleavage of the peptide from the fusion protein 
after 4 hours, HPLC purification was carried out for the separated supernatants. The 
supernatant of the CNBr cleaved mixtures after centrifugation were run on the C 18 
HPLC column. The HPLC purification protocol was initiated with injection of 0.5 ml 
supernatant. The 0.5 ml supernatant eluted from the C18 column from 70% water/30% 
acetonitrile (with 0.1% trifluoroacetic acid, TF A} to 70% acetonitrile/30% water (with 
0.1% TFA) gradient over 40 minutes. There were two major peaks observed after the 
injection peak [Figure 3.6] . The two peaks (peak 1 and 2) were collected separately. The 
collected peak fractions were pooled. The acetonitrile and TF A in the collected peak 
fractions were removed by rotary-evaporation, which was followed by lyophilization. 
Tricine gel results confirmed the purity of the collected peak fraction and suggested a 
slight molecular weight difference between the two peak fractions, which was further 
confrrmed by mass spectrometry (performed by the Molecular Biology Core Facilities at 
Dana Farber Cancer Institute, Boston, MA}. A 27 Da molecular weight difference was 
determined but it was uncertain as to the kind of residue modification that gave rise to 
this 27 Da difference or the kind of point mutation that may have happened during the 
transformation and peptide expression processes. Tricine gel results show the band of 
Peak 1 is very close to the CSP-ABAB peptide's theoretical molecular weight. The exact 
molecular mass of peak 1 was confrrmed as 5220 Da by mass spectrometry as in [Figure 
3.7A] 
-58-
1100.1XI 
1000.00 IJ:UeCtiOft Peak 
1100.00 Pealc1 -
1100.00 
700.00 
800.00 
> 
" 800.00 
400.00 
300.00 
:200.00 
100.00 
0.00 
0.00 2.00 4.00 5.00 SDCI t O.OO 12.00 14.00 IB.OO 11.00 20.00 22.00 24.00 2$.00 2UO 30.00 32..00 34..00 31!.00 
!S2~es. 3tS.1H!I7mV t.4hl:.t• 
Figure 3.6 Representative HPLC chromatograph. 0.5 ml injection of protein run on 
C18 column from 30% acetonitrile to 70% acetonitrile in water over 40 minutes. Two 
peaks #1 and #2 were observed. 
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Mass spectrum for unlabeled CSP-ABAB 
The purified peptide's molecular weight was determined as 5220 Da, which is consistent 
with the CSP-ABAB's theoretical molecular weight (5220 Da). Thus, the peptide's 
molecular weight was confirmed [Figure 3.7 A]. 
Mass spectrum for 15N labeled CSP-ABAB 
The 15N labeled peptides were purifi.ed with the same elution program as the unlabeled 
peptide. The HPLC results were the same as for the unlabeled peptide. Peak 1 represents 
the expected target peptide. The purified peptide ' s molecular weight was determined as 
5291 Da. The 15N labeled CSP-ABAB's theoretical molecular weight is 5296 Da [Figure 
3.7B]. 
Mass spectrum for 13C and 15N labeled ABAB 
The 13C and 15N labeled peptides were purified with the same elution program as the 
unlabeled peptides with HPLC results the same with the previous two. Peak 1 was the 
expected target peptide. The purified peptide's molecular weight was determined as 5514 
Da. The 13C and 15N labeled CSP-ABAB's theoretical molecular weight is 5520 Da 
[Figure 3.7 C]. 
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Figure 3. 7 A Mass spectrum of the collected peak 1 fraction of the unlabeled CSP-
ABAB. The major protein component is 5220 Da. 
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Figure 3. 7 B Mass spectrum of the collected peak 1 fraction of the 15N labeled CSP-
ABAB. The major protein component is 5291 Da. 
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Figure 3.7 C Mass spectrum of the collected peak 1 fraction of the 15N, 13C labeled 
CSP-ABAB. The major protein component is 5514 Da. 
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Quantitative amino acid analysis 
Although the molecular weight of the purified peptide was confirmed to be consistent 
with CSP-ABAB's theoretical molecular weight, the peptide composition still required 
further confirmation and the concentration of the purified peptide needed to be accurately 
determined. The quantitative amino acid analysis not only confirmed the composition of 
the purified peptide and substantiated the sequence authenticity and purity, but also 
provided a method for accurate concentration determination. 
This method is especially important for the CSP-ABAB peptide, because the deficiency 
of aromatic amino acids within the sequence excluded applying the usual concentration 
measurement methods such as Bradford or Lowry assay to determine the concentration. 
The analysis was performed at the Molecular Biology Core Facilities at Dana Farber 
Cancer Institute (Boston, MA). The actual amino acid numbers present in the peptide are 
very close to the theoretical number [Figure 3.8, 3.9]. Edman degradation, which was 
also performed at the Molecular Biology Core Facilities at Dana Farber Cancer Institute, 
and the result confirmed the first five residues of the purified peptide to be PLAEE. 
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Tbe sequeoce of the CSP-ABAB 
P EE R R R Q EE RER GP EE R R R Q EE RER G 
I A I B I A I B I 
Figure 3.8 A representative HPLC chromatogram of the quantitative amino acid 
analysis used to determine the concentration of CSP-ABAB. 
Name #residues #residues 
experiment theoretical 
ASX 0.5 
SER 0.3 
GLX 10.2 12 
GLY 2.1 2 
HIS U.4 
NH3 0.0 
ARG 10.8 . 10 
THR 0.0 
ALA 5.5 6 
PRO 1.9 2 
IIBA 0.0 
TYR 0.2 
VAL 0.4 
MET 0.0 
LYS 0.3 
! ILE 0.2 
LEU 11.0 12 
PHE 0.2 
Figure 3.9 Quantitative amino acid analysis results of purified CSP-ABAB. The 
residues type and numbers ofthe amino acid analysis matched CSP-ABAB. 
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3.3 Circular dichroism studies of recombinant CSP-ABAB 
Once the authenticity and the accurate concentration of the CSP-ABAB had been 
determined, the secondary structure ofthe CSP-ABAB was explored by far-UV circular 
dichroism (CD). The CSP-ABAB samples were prepared in 5 rnM phosphate buffer at 
pH 7.4. Their concentrations range from 0.005 mg/ml to 0.5 mg/ml. All the peptide 
samples were investigated by far-UV CD from 185 nm to 250 nm at 25 'C. The far-UV 
CD spectra demonstrated that all the peptide samples were well-folded and all samples 
showed a high a-helical content [Figure3.10]. 
The helical content of the peptide in Phosphate buffer, which is proportional to the mean 
residue molar ellipticity of target peptide, was examined over a concentration range from 
0.005 mg/mL to 0.5 mg/mL. Based on the far-UV CD spectral data, the mean residue 
molar ellipticity for each sample was calculated by normalization. After the 
normalization, all the samples within the concentration range studied had approximately 
the same mean residue molar ellipticity at 222 nm, demonstrating that the a-helical 
content for all the peptide samples is independent of concentration [Figure 3.11]. Thus 
the CSP-ABAB peptide does not self-associate within this concentration range from 
0.005 mg/mL to 0.5 mg/mL. 
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Figure 3.10 Far-UV CD spectra of CSP-ABAB in pH 7.4 PB. All spectra were 
recorded at 25 ·c with 1-mm or 2-mm cell path length, corrected against baseline of 
buffer alone. 
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Figure 3.11 The mean residue mola r ellipticity of CSP-ABAB peptide from 0.005 
mg/mL to 0.5 mg/mL in 5 mM PB with pH 7.4. 
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As described in Chapter 2, the a-helical content of each sample was calculated and 
determined as a function of sample concentration shown in [Figure 3.12]. Based on the 
curves, over a 100 fold concentration range, the CSP-ABAB peptide was well-folded in 
solution and contained more than 60% a-helical structure. The mean value of ~ 62%, 
demonstrating that the main conformation of the peptide in solution is a-helical structure, 
consistent with our previous structural conclusion about the CSP-ABAB 
e: t " [Chao, 2003, Dong, 2008] 
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Figure 3.12 The a-helical content of CSP-ABAB peptide from 0.005 mg/mL to 0.5 
mg/mL in 5 mM PB with pH 7.4. The mean value of the a-helical content is 62%. 
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The far UV CD spectra for samples with concentration 0.2 mg/mL at pH 5, 6 and 7.4 is 
shown in [Figure. 3.13] . No significant change in the spectrum from 200 nm to 230 nm 
was observed and the helical content did not change with the pH from 5, 6 to 7.4. 
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Figure 3.13 The far-UV CD spectra of CSP-ABAB peptide at 0.2 mg/mL in 5 mM 
PB with pH 5, 6, 7 .4. 
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Thermal unfolding data of CSP-ABAB at various peptide concentrations monitored by 
the CD signal at 222 nm are shown in [Figure 3.14] . The two lines of each color are 
heating and cooling separately. The temperature range ofthe scans was 1 'C to 96 'C for 
all the samples with concentrations from 0.1 mg/mL to 0.5 mg/mL. The scan rate was 1 
deg/min. The thermal unfolding data of CSP-ABAB at different concentrations showed 
similar melting curves. The melting curves of CSP-ABAB showed non-cooperative 
unfolding, indicating the lack of substantial tertiary structure in the peptide over this 
concentration range. and also further substantiating that the peptide does not self-
associate. 
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Figure 3.14 Melting curves of CSP-ABAB peptide with different concentrations at 
pH 5 and 7.4. 
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Chapter 4 NMR structure determination 
4.1 Resonance assignment 
4.1.1 Resonance assignment of backbone atoms 
The CSP-ABAB samples for NMR experiments were prepared by combining 2mM 
lyophilized protein powder, 10% DzO (Deuterated water), 20mM NaH2P04, 0.05% 
NaN3, and 10 nM TMSP to 550 ul in a 5 mm Shigemi tube. 
Preliminary 1 D and 2D NMR experiments were run at different pH and temperature on 
the 500 MHz spectrometer to find the optimized condition. The pH value varied from 5, 
5.5 , 6, to 8 and the temperature varied from 283K to 298K. The spectrum with the best 
resolution was achieved at pH 5.5 and 293K. This optimized pH value (5.5) and 
temperature (293K) was used for all the following NMR experiments, including the 
NMR experiments performed on the 800 MHz spectrometer for structure determination 
[Figure 4.1]. 
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Figure 4.1 The 1H-15N HSQC spectrum of CSP-ABAB (pH 5.5, 293K, 800MHz). 
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After the sample working conditions were optimized, a set of 2D and 3D NMR 
experiments were run on the 800MHz NMR spectrometer at Brandeis University to 
achieve higher resolution and sensitivity for the structure calculation. The most straight 
forward strategy of backbone resonance assignment for the 15N, 13C-labelled CSP-ABAB 
peptide was the measurement of HNCA, HN(CO)CA, HNCO and HN(CA)CO spectra. 
Here, the HNCA, HN(CO)CA, HNCACB spectra are sufficient to carry out the full 
assignment. The NMR data were processed with Topspin 3.1 [Bruker, Bellerica, MAJ. The peak 
picking and resonance assignment were carried out with the software CCPNMR 2.2 
(c 11 b · C · p · .c: NMR)[Vranken WF et al ?005] CCPNMR · · o a orat1ve omputmg roJect 10r ' ' - . IS a proJect 
that aims to perform a similar service for NMR spectroscopists, especially in the field of 
· NMR h · fCCP4 [MD Winnetal 2011]. h X . protem , tot e serv1ce o · · · m t e -ray commumty. 
Although the peptide assignment is complicated by the intrinsically · degenerate 
sequence, the spectra were satisfactory for assignment purposes. For example, in the 15N-
HSQC spectrum there were a total of 38 separated backbone cross-peaks. Considering 
that the 44 residue peptide has two proline residues without the NH cross-peak and one 
proline at the begining, the expected number of backbone cross peaks is 40, the number 
of missing peaks (i.e. 4) was acceptable. 
To start the assignment, all the residues were divided to individual spin systems based 
on each individual NH group. The special repetitive pattern of certain amino acids in 
CSP-ABAB provided a good starting point for the sequential backbone assignment. 
Assignment of the two Gly spin systems (Gly22 I Gly44) and two Gln spin systems 
(Gln13 I Gln35) was started first, since Gly has a very unusual carbon alpha chemical 
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shift among all ofthe amino acids that the protein contains at around 45 ppm. There are 
only two Gln residues with the preceding residues Alal2 I 34, and Ala has a very special 
carbon beta chemical shift around 15 ppm compared to the carbon beta chemical shift of 
other residues. The above residues' special chemical shift value and the residues' position 
in the peptide gave the sequential assignment an easy start. The Gly Ca resonance 
narrows down the possible cross peaks on the 13C-HSQC spectrum [Figure 4.2]. There 
are only two cross peaks on 13C-HSQC having the Ca at 42.36 ppm and 42.53 ppm. 
Thus, they were tentatively assigned as Gly22 /Gly44. The backbone assignment 
continued to residue Leu21 and Leu43 in the order of residue (i) to residue (i-1). 
-E 
a. 
a. 
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0 (\") 
...... 
1 H (ppm) 
Figure 4.2 Two glycine residues on the 2D 1H-13C HSQC spectrum of CSP-ABAB. 
Only Glycine has two Ha. The Ca of Gly44 is 42.36 ppm, the Ca of Gly22 is 42.52 
ppm. 
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The CSP-ABAB backbone resonances were completely assigned on the 1H,15N-HSQC 
spectra except the two Proline residues [Figure 4.3] based on the three 3D-HNCA, 
HN(CO)CA and HNCACB spectra. However, there is still one uncertainty about the 
backbone assignment. Since the previous Gly22 and Gly44 assignment is temporary and 
exchangeable, all ofthe following backbone assignments could be assigned as its repeat 
residue (i+22). This ambiguity was resolved with the help of the 3D NOESY spectra. 
The difference between Gly22 and Gly44 is their through-bond interactions. Gly22 has 
more sequential (residue i,i+ 1) NOEs compared to Gly44. 
The 3D 15N-NOESY-HSQC experiment used the pulse program "noesyhsqcfpf3gpsi3d" 
which uses a flip-back pulse and f3 channel. [62•63•641 The mixing time was 150 ms, which 
is a slightly long mixing time for the small size of the CSP-ABAB protein. At long 
NOESY mixing times the magnetization maybe exchanged between all hydrogens (spin 
diffusion). Finally, the magnetization is transferred to the amide nitrogen and amide 
proton for detection. Theoretically the 15N-NOESY-HSQC shows crosspeaks to all the H 
resonances which are within~ 6 A of the NH hydrogen for each individual spin system. 
Sequential NOEs can be used to check the backbone assignment. The amide region of 
the 15N-NOESY-HSQC spectrum was used to double check and confirm the backbone 
assignment based on the triple resonance spectra described above. The 3D 15N-NOESY-
HSQC spectra provided the basis for the NOEs assignment and generation of the NOE 
derived distance restraints. Both the NOE peak list and distance restraints were essential 
for the three dimensional structure calculations described later. 
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Figure 4.3_A 2D Assigned 1H/5N HSQC spectrum ofCSP-ABAB (pH 5.5, 293K). 
The unlabeled peaks area of Figure A is zoomed and individually labeled in the Figure B. 
*Note: Two most upfield-shifted peaks (Gly22, Gly44) are not shown in Figure A. 
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Figure 4.3_B. 2D Assigned 1H,15N HSQC spectrum ofCSP-ABAB (pH 5.5, 293K). 
Figure B shows the unlabeled peaks area of Figure 4.3 _A. The area is zoomed and the 
peaks are individually labeled in the Figure B. 
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4.1.2 Resonance assignment of side-chain atoms 
To further use the 15N-NOESY-HSQC spectra for NOE assignment and structure 
calculation, the side-chain carbon and hydrogen atoms needed to be assigned. The 
strategy was to use the 2D 13C-HSQC, 3D HNcoCACB and 3D HCCH-TOCSY to assign 
the side chain carbon and proton chemical shift of all the 44 spin systems, including the 
two proline residues. The 3D HCCH-TOCSY experiments used the Bruker standard pulse 
program "hcchdigp3d" and the standard parameter set "HCCHDIGP3D" [A D. Bax, et aL , 1990• 
E.T. Olejniczak, et aL, 19921. The experiment starts with the magnetization transferred from the 
side-chain hydrogen nuclei to their attached 13C nuclei. An isotropic 13C mixing process 
follows and then the magnetization is transferred back to the side-chain hydrogen atoms 
for NMR detection. The 3D HCCH-TOCSY spectra yields the CH strips at each side 
chain carbon frequency. Each strip contains all the visible hydrogen resonances attached 
to the carbon atoms in the same side chain, as for Gly22 and Gly44 shown in [Figure 
4.4]. The chemical shift assignments used for CSP-ABAB structure calculation are listed 
in [Table 4.1] , the assigned but uncertain chemical shifts are not listed and were not used. 
The amide proton and nitrogen chemical shift information was unavailable for the two 
proline residues (Pro 1 and Pro23). 
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Figure 4.4 CH plane ofthe 3D HCCH-TOCSY spectrum ofCSP-ABAB at 13C 42.52 
ppm. The CH plane at 13C 42.52 ppm contains all the TOCSY peaks that belong to the 
Gly22 spin system. The proton resonances attached to the alpha protons of Gly22 are 
shown in this plane. The TOCSY peaks of the Gly44 spin system were also present 
because its alpha carbon is at 42.36 ppm, very close to Gly22. 
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Table 4.1 Chemical shift assignments for CSP-ABAB (pH 5.5, 293K, ppm) 
H N Hu HP1 HP2 Ca cp other 
1 Pro 4.38 2.35 2 62.23 29.14 
2 Leu 8.79 122.58 4.34 1.7 1.63 53.58 39.59 
3 Ala 8.82 124 4.17 1.47 51.9 15.7 
4 Glu 8.4 117.41 4.09 2.34 2.08 56.03 25.58 
5 Glu 8.02 120.22 4.17 2.16 2.2 55.57 25.64 
6 Leu 8.09 121.54 4.13 1.62 1.76 55.07 38.91 
7 Arg 8.33 118.35 3.79 1.94 1.85 57.42 27.49 Hya=l.51 
8 Ala 7.87 119.77 4.09 1.55 52.45 15.21 
9 Arg 7.98 119.82 4.17 2.02 1.97 56.53 27.42 
10 Leu 8.29 121.11 4.16 2 1.32 55.28 39.41 Hoa·=o.8o 
11 Arg 8.62 118.29 3.95 1.9 1.95 57.48 27.31 Hya=l.61 
12 Ala 7.9 121.67 4.23 1.56 52.34 15 
13 Gin 8.06 118.95 4.08 2.29 2.1 56.34 26.24 Hya=2.62 
Hyb=2.33 
14 Leu 8.33 120.48 3.98 1.77 1.63 55.41 39.1 
15 Glu 8.17 119.62 4.17 2.15 2.2 55.73 25.1 
16 Glu 7.95 119.06 4.16 1.76 2.19 55.59 25.21 
17 Leu 7.76 119.19 4.17 1.59 1.87 54.12 39.44 
18 Arg 7.92 119.75 4.11 1.87 2.02 55.43 27.34 
19 Glu 8.05 118.41 4.2 2.32 2.11 54.37 25.93 
20 Arg 7.99 119.53 4.31 1.87 1.92 54.13 28.03 
21 Leu 8.2 121.02 4.4 1.75 1.63 52.48 39.89 
22 Gly 7.99 112.8 3.92 42.52 
3.85 
23 Pro 4.45 2.52 2.1 59.6 29.48 
24 Leu 8.01 120.44 4.24 1.63 1.73 54.92 38.19 
25 Ala 8.11 122.25 4.04 1.32 52.16 15.48 
26 Glu 7.85 116.46 4.18 2.19 2.14 56.37 25.38 
27 Glu 8.13 119.94 4.15 2.2 2.14 55.92 25.16 
28 Leu 8.19 121.07 4.14 1.85 1.61 55.07 39.03 
29 Arg 8.52 118.51 3.83 1.76 2.02 57.77 27.93 Hoa=3.18 
30 Ala 8.03 120.19 4.22 1.56 52.59 15.04 
31 Arg 8.04 120.09 4.16 1.98 2.02 56.54 27.37 
32 Leu 8.33 120.54 4.16 1.32 2 55.25 39.25 
33 Arg 8.45 117.79 3.95 1.95 1.88 57.25 27.23 
34 Ala 7.96 121.82 4.07 1.55 52.35 15.06 
35 Gin 8.1 119.21 4.05 2.29 2.33 56.32 26.3 Hya=2.59 
Hyb=2.33 
36 Leu 8.43 120.67 4.02 1.86 1.67 55.38 39.19 
37 Glu 8.16 119.46 4.12 2.13 2.23 56.11 25.16 
38 Glu 7.89 118.62 4.16 2.18 1.77 55.46 25.3 
39 Leu 7.65 117.65 4.24 1.59 1.88 52.65 40.84 
40 Arg 7.67 121.88 4.03 2.03 1.92 57.28 27.86 
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Table 4.1 Continued. 
H N Ha. HP1 HP2 Ca. cp other 
41 Glu 8.40 114.78 4.39 2.41 2.34 52.90 25.48 
42 Arg 7.51 119.60 4.35 1.82 1.77 53.22 27.84 
43 Leu 8.61 124.10 4.63 1.60 1.78 51.82 41.27 
44 Gly 8.48 108.94 4.04 42.36 
4.50 
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4.2 Structural information 
4.2.1 Dihedral restraints 
The assigned chemical shifts listed in [Table 4.1] were used to derive the dihedral 
constraints for structural information of the CSP-ABAB peptide. The dihedral restraints 
were calculated with the software TALOS+ (Prediction of Protein Backbone Torsion 
Angles from Chemical Shifts) [Y Shen. et aL, 2009] . T ALOS+ is a hybrid system for empirical 
prediction of protein phi and psi backbone torsion angles based on the assigned chemical 
shifts for a given residue sequence. Usually the input chemical shift combination for 
calculation is HN, Ha, Ca, q3, CO and N. In this work, the assigned chemical shift 
combination ofHN, Ca, Cf3 and N was used for the torsion angle calculations. The input 
format of the chemical shift for TALOS+ calculation were named as follows: Ha for 
alpha proton (except glycine); Ha2 and Ha3 used for the two alpha protons of glycine 
residues; Ca for carbon alpha; Cf3 for carbon beta; N for amide nitrogen; HN for amide 
proton. 
The summary of results for the calculated phi and psi, the estimated standard deviations 
and the classification of the prediction results is listed in [Table 4.2] . The residues of 
Leu21-Glu26 do not have good torsion angle predictions. The residues at the protein end 
Arg42, Leu43 and Gly44 have dynamic conformations. Only the good predictions were 
used to generate the dihedral restraints. A total of 68 dihedral restraints were generated 
based on the good torsion angles predicted in Table 4.2. 
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Table 4.2 Protein backbone torsion angle table of CSP-ABAB. 
PHI PSI DPHI DPSI CS COUNT CLASS 
1 p 8 None 
2 L -78.323 -21.928 22.933 22.507 13 Good 
3 A -62.957 -41.88 4.077 4.715 15 Good 
4 E -61.732 -40.792 5.023 6.657 15 Good 
5 E -65.193 -39.629 5.905 4.141 15 Good 
6 L -65.93 -39.728 4.081 4.768 15 Good 
7 R -60.659 -38.395 4.952 10.959 15 Good 
8 A -66.578 -38.353 13.323 8.069 15 Good 
9 R -64.211 -43.651 2.905 4.13 15 Good 
10 L -63.136 -44.213 4.688 5.315 15 Good 
11 R -61.599 -37.231 4.904 9.634 15 Good 
12 A -66.058 -38.995 12.637 7.116 15 Good 
13 Q -65.606 -43.484 2.64 4.948 15 Good 
14 L -61.929 -42.285 4.028 4.051 15 Good 
15 E -64.73 -41.574 6.401 8.45 15 Good 
16 E -64.382 -38.392 4.189 9.858 15 Good 
17 L -64.211 -43.107 6.87 7.218 15 Good 
18 R -64.812 -39.453 8.8 9.805 15 Good 
19 E -68.411 -31.391 12.83 18.816 15 Good 
20 R -78.13 -30.182 20.276 16.072 15 Good 
21 L -73.144 129.408 59.725 14.836 14 Warn 
22 G -69.771 149.103 52.575 30.82 12 Warn 
23 p -59.446 -29.628 8.99 9.243 12 Bad 
24 L -65.884 -36.758 6.08 10.829 13 Bad 
25 A -61.647 -41.12 3.751 5.278 15 Bad 
26 E -63.701 -43.572 5.052 5.756 15 Bad 
27 E -65.701 -39.336 5.729 3.823 15 Good 
28 L -63.499 -39.499 5.296 4.503 15 Good 
29 R -60.16 -41.194 4.593 11.452 15 Good 
30 A -64.993 -39.133 12.906 7.15 15 Good 
31 R -66.445 -41.941 3.524 4.784 15 Good 
32 L -62.533 -40.557 4.706 8.883 15 Good 
33 R -61.667 -38.379 4.219 10.062 15 Good 
34 A -67.572 -38.993 11.883 7.558 15 Good 
35 Q -67.904 -42.942 3.809 5.871 15 Good 
36 L -61.364 -40.975 4.863 4.485 15 Good 
37 E -64.621 -41.123 6.682 5.749 15 Good 
38 E -66.682 -33.551 7.586 12.359 15 Good 
39 L -87.363 -16.454 16.664 21.212 15 Good 
40 R -60.883 -35.619 5.042 9.469 15 Good 
41 E -96.196 3.654 9.284 14.586 15 Good 
42 R -80.689 134.355 30.961 38.452 15 Warn 
43 L -72.296 144.195 48.186 36.821 14 Dynamic 
44 G 9 None 
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Table 4.2 Continued. 
DPHI and DPSI are the estimated standard deviations of the prediction errors in PHI and 
PSI (degrees). COUNT is the number of database triplets used to form the torsion angle 
predictions. Class is the classification of the prediction result: 
None : no torsion prediction was made. 
Good: majority consensus in database matches; prediction is likely to be good. 
Warn: no consensus in database matches, do not use prediction. 
Dyn : indicates that residue has dynamic conformation. 
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4.2.2 Distance restraints 
The NOE assignments were carried out using the 2D 1H- 15N HSQC, 1H-13C HSQC and 
the 3D HSQC-NOESY spectra. Initially the NOEs are automatically assigned, then the 
assigned NOEs are manually checked, lots of automatically assigned NOEs with 
overlapping problem are discarded. There were total 611 assigned NOE crosspeaks kept 
and used. Among the total assigned 611 through-space connectivities, 230 are intra-
residue through-space connectivies, 381 are inter-residue through-space connectivites. Of 
the 381 inter-residue NOEs, 307 are sequential (i, i+ 1) through-space connectivities, 373 
are short range (i, i+2) through-space connectivites, 66 are short range non-sequential and 
8 are long-range (i > i+5) through-space connectivites. Based on the assigned NOEs, 536 
distance restraints were generated. The restraint distance parameters use the intensity 
type. The distance is proportional to the NOE intensity/\-1/6. The lower distance limit 
was set as 1. 72 A and upper distance limit was set to 8.0 A. 
The 68 dihedral restraints generated based on the "good" predicted torsion angles by 
T ALOS+ and the 536 distance restraints generated based on the assigned NOEs peak list 
were used to calculate the three-dimensional structure of the CSP-ABAB. 
4.3 Structure determination 
4.3.1 Determination of the secondary structure 
The secondary structure ofCSP-ABAB was elucidated in a two ofways. Firstly, the CD 
data described in Chapter 3 shows the major conformational motif of CSP-ABAB is a-
helix and the helical content is about 62%. Thus ~27 residues of the total44 residues are 
helical. 
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With the backbone and side-chain chemical shift assignments accomplished, the NMR 
data itself can be used as secondary structure indicators of each individual residue. The 
secondary structure per residue was specified manually based only on each individual 
residue NMR data as shown in the residue NMR data table [Table 4.4]. Each residue's 
secondary structure definition was decided with a full consideration of the chemical shift 
values and the characteristic NOEs. The dNN (i,i+I) is the NOE intensity between two 
sequential amide proton, which is the characteristic of a-helix structure. The CSI 
(chemical shift index) value calculated by CCPNMR, indicates the secondary structure of 
each residue present in solution. There are two helices indicated on the secondary 
structure chart derived from the residue NMR data table, Ala3-Arg18, and Arg29-Arg40. 
There are also other tools capable of predicting the dihedral angles based on the 
backbone chemical shifts assignment, like TALOS+ and DANGLE (Dihedral Angles 
from Global Likelihood Estimates) [Cheung MS, et aL , 20101 • The DANGLE results indicated the 
residues Arg7-Ala12 and Glu27-Ala34 are a-helical. For some residues like Arg20, 
Leu21 , Gly22, Pro23, Leu24 and Ala25, the angle prediction is either out ofthe a region 
or in multiple regions in the Ramachandran plot. These observations indicate the 
uncertainty of the angle prediction and that DANGLE was not able to make a distinct 
choice of PHI/PSI angles for these residues. These uncertain predictions can not be used 
for structure calculation, but they indicate that at least 14 residues are always helical. 
T ALOS+ works in a similar manner to DANGLE. Besides the dihedral angle prediction, 
T ALOS+ also predicts the protein secondary structure. According to the predicated 
results, sequence Glu4-Argl8 and Leu24-38Glu are helical. The prediction confidence of 
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each residue by T ALOS+ is listed in [Table 4.5]. Both DANGLE and T ALOS+ agree in 
the a-helical secondary structure certainty ofthe following two helical sequences: Arg7-
Ala12 and Glu27-Ala34. 
Taken together, the secondary structural information indicated or predicted based on the 
NMR data was consistent with the secondary structure suggested by the previous CD 
experiment results in Chapter 3. Both the TALOS+ prediction and the NMR information 
itself for each residue indicate the following 25 residues are helical: Glu4-Arg18, Arg29-
Glu38, and other residues like Ala3, Leu24-Glu27, and Leu28 are conformational 
dynamic and may switch between turn and helical conformations. 
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Table 4.3 Secondary structure of CSP-ABAB indicated by NMR data per residue. 
Res 2nd daN d NN d BN L'l813Cu L'l813CB L'l81Hu CSI 
structure (i,i+ 1) (i,i+ 1) (i,i+ 1) 
Pro -0.65 -5.66 -0.16 0 
2 Leu M M -1 .72 -2.86 0.04 1 
3 Ala Alpha M w -0.89 -3.55 -0.08 -1 
4 Glu Alpha M M M -0.04 -3.30 -0.22 -1 
5 Glu Alpha M s w -0.47 -3 .25 -0.17 -1 
6 Leu Alpha w M M -0.36 -3.54 -0.19 0 
7 Arg Alpha w M 1.06 -3.43 -0.49 -1 
8 Ala Alpha M s M -0.29 -4.05 -0.17 -1 
9 Arg Alpha M M M 0.07 -3 .51 -0.12 -1 
10 Leu Alpha w M M -0.10 -3.04 -0.15 0 
11 Arg Alpha w M M 1.14 -3.62 -0.34 -1 
12 Ala Alpha M s M -0.41 -4.25 -0.03 -1 
13 Gin Alpha M M M 0.15 -3.28 -0.22 -1 
14 Leu Alpha M s M -0.02 -3.36 -0.34 -1 
15 Glu Alpha M M M -0.31 -3.77 -0.13 -1 
16 Glu Alpha M s M -0.48 -3.66 -0.20 -1 
17 Leu Alpha s M -1.32 -3.01 -0.15 
18 Arg Alpha M s M -1.01 -3.58 -0.17 -1 
19 Glu M s w -1.64 -2.95 -0.12 
20 Arg M M -2.31 -2.90 -0.01 
21 Leu w s w -2.77 -2.57 0.04 1 
22 Gly -0.90 1 
23 Pro M M -3.30 -5.32 -0.09 0 
24 Leu M s M -0.38 -4.26 -0.06 
25 Ala w M -1.96 -3.78 -0.21 -1 
26 Glu M M 0.28 -3.49 -0.14 -1 
27 Glu M s -0 .12 -3.72 -0.18 -1 
28 Leu M -0.37 -3.42 -0.18 0 
29 Arg Alpha M M 1.41 -3.00 -0.45 -1 
30 Ala Alpha M s -0.15 -4.21 -0.03 -1 
31 Arg Alpha M M s 0.02 -3.52 -0.15 -1 
32 Leu Alpha M s M -0.13 -3.21 -0.16 0 
33 Arg Alpha w M M 0.9 -3.69 -0.33 -1 
34 Ala Alpha M s M -0.41 -4.20 -0.18 -1 
35 Gln Alpha M M M 0.11 -3.22 -0.22 -1 
36 Leu Alpha M M -0.05 -3.26 -0.31 -1 
37 Glu Alpha M M M 0.07 -3.70 -0.19 -1 
38 Glu Alpha M s M -0.60 -3.58 -0.18 -1 
39 Leu Alpha w s M -2.80 -1.61 -0.08 
40 Arg Alpha w w M 0.83 -3.07 -0.25 -1 
41 Glu M M -3 .12 -3.39 0.05 
42 Arg M -3.24 -3.09 0.01 
43 Leu M s M -3.65 -1.18 0.26 
44 Gly -3.08 1 
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Table 4.3 Continued. 
NOE intensities are classified into: S (Strong), M (Medium) and W (Weak) based on the 
average NOE peak intensity in the whole peak list. Chemical shift differences are defined 
as: difference= observed- random coil. ~813Ca is the difference between the observed 
chemical shift and the random coil value of 13Ca. ~8 13CI3 is the difference between the 
observed chemical shift and the random coil value of 13CI3. ~o lHa is the difference 
between the observed chemical shift and the random coil value of lH-alpha. CSI (the 
chemical shift index) is the classification of chemical shift differences into three type : -1, 
0 and 1. The CSI value "-1" indicates alpha helix, "0" means no indication, and "1" 
indicates beta sheet. [Wishart, D S ' et aL , 1994] 
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Table 4.4 The secondary structure prediction of CSP-ABAB. 
RES CS CNT Q_H Q_E Q_L CONFIDENCE SS_CLASS 
p 8 0.333 0.333 0.333 0 L 
2 L 13 0.849 0.009 0.142 0.71 H 
3 A 15 0.953 0 0.047 0.91 H 
4 E 15 0.984 0 0.016 0.97 H 
5 E 15 0.995 0 0 .005 0.99 H 
6 L 15 0.997 0 0.003 0.99 H 
7 R 15 0.995 0.001 0.004 0.99 H 
8 A 15 0.998 0.001 0.002 1 H 
9 R 15 0.993 0.002 0.005 0.99 H 
10 L 15 0.997 0.001 0.002 0.99 H 
11 R 15 0.995 0.002 0.003 0.99 H 
12 A 15 0.998 0.001 0.001 1 H 
13 Q 15 0.993 0.001 0.005 0.99 H 
14 L 15 0.995 0 0.005 0.99 H 
15 E 15 0.991 0.001 0.008 0.98 H 
16 E 15 0.994 0 0.006 0.99 H 
17 L 15 0.987 0 0.013 0.97 H 
18 R 15 0.953 0 0.047 0.91 H 
19 E 15 0.874 0 0.126 0.75 H 
20 R 15 0.682 0.004 0.314 0.37 H 
21 L 14 0.142 0.015 0.843 0.7 L 
22 G 12 0.027 0.034 0.94 0.91 L 
23 p 12 0.78 0.027 0.194 0.59 H 
24 L 13 0.983 0 0.017 0.97 H 
25 A 15 0.992 0 0.008 0.98 H 
26 E 15 0.988 0.002 0.01 0.98 H 
27 E 15 0.997 0 0.003 0.99 H 
28 L 15 0.997 0.001 0.002 0.99 H 
29 R 15 0.995 0.001 0.004 0.99 H 
30 A 15 0.998 0.001 0.002 1 H 
31 R 15 0.993 0.002 0.005 0.99 H 
32 L 15 0.997 0.001 0.003 0.99 H 
33 R 15 0.994 0.001 0.005 0.99 H 
34 A 15 0.997 0.001 0.002 I H 
35 Q 15 0.994 0.001 0.005 0.99 H 
36 L 15 0.994 0 0.006 0.99 H 
37 E 15 0.987 0 0.012 0.98 H 
38 E 15 0.98 0 0.02 0.96 H 
39 L 15 0.929 0 0.071 0.86 H 
40 R 15 0.737 0 0.263 0.47 H 
41 E 15 0.395 0.007 0.598 0.2 L 
42 R 15 0.101 0.054 0.844 0.74 L 
43 L 14 0.087 0.115 0.798 0.68 L 
44 G 9 0.333 0.333 0.333 0 L 
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Table 4.4 Continued. 
H stands for helix, E stands for strand, L stands for coil. CS _ CNT is calculation times ofT ALOS 
for each residue. Confidence value indicates the probability of each residue's prediction. 
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4.3.2 Determination of the three-dimensional structure 
The three dimensional structure determination was carried out with the software ARIA 
2 3 [Rieping w et al ?007J ARIA (Amb' R · c. I · A · · . ' ' - . 1guous estramts 10r teratrve ss1gnment) 1s a 
software package for automatic NOE assignment and NMR structure calculation. 
Basically it uses an iterative structure calculation scheme to automatically carry out the 
assignment and calculation. 
In this study, the initial 10 CSP-ABAB conformers were calculated with the combined 
restraints lists ofthe 74 dihedral constraints and 536 distance constraints. The 74 dihedral 
constraints were generated from the predicted dihedral angles as listed in [Table 4.2]. 
The distance restraints were used for ARIA to automatically calibrate the NOE restraints 
according to the volumes of the integrated peaks. 
The total 536 restraints were divided into one unambiguous distance constraints group 
(528 constraints) and one ambiguous distance constraints group (8 constraints). The two 
group constraints were treated differently before being used for structure calculation. The 
. l ft CNS [AT . Brunger et al. 1998] b dd d . h ARIA ft k mterna so ware ' ' em e e m t e so ware pac age 
iteratively performs the calculations for eight iterations. After each iteration, ARIA 
analyzes the 20 conformers generated by CNS and updates the restraints set. After eight 
calculation iterations, the last step of each ARIA run is to refme the calculated 20 
structure conformers generated from the 81h iteration in explicit water through molecular 
dynamics. 
In the fmal refinement and analysis step, ARIA generates 10 energy minimized 
conformers, provides a quality analysis and report ofthe 10 refined conformers using the 
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. l l . l p h k [LaskowskiRA 1993] Th 1. · l d h 1. . mterna ana ysts too roc ec ' . e qua tty report me u es t e qua ttatlve 
analysis of the structural statistics for the CSP-ABAB ensembles. 
The new restraints set returned after the gth iteration of ARIA was imported to 
CCPNMR. The restraints violations were checked and reassigned manually referring to 
the 1 0 conformers. 
In this study, the advantage of choosing ARIA 2.3 over other NMR structure calculation 
software is its compatibility with the CCPNMR software, since all the previous 
assignment was carried out with CCPNMR. The fmal refined structures calculated by 
ARIA 2.3 together with the updated constraints sets can be imported directly into the 
CCPNMR project. The validated constraints can then be checked and the 10 conformers 
can be further refined, which avoids the possible tedious format exchange processes with 
other NMR data processing software. 
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Figure 4.5. The structure calculation flowchart. Every ARIA structure calculation 
cycle refined the 10 conformers uses the same 74 dihedral constraints set and the updated 
distance constraints set including ~ 500 distance restraints. The updated distance 
constraints set and the generated strcutres were exported to CCPN for quality check. 
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Each ARJA run contained eight iterations and one fmal refinement. Twenty conformers 
were generated after each iteration and 1 0 refined conformers were generated after the 
fmal water refmement. A new updated restraints set was generated also with the 
completion of each ARJA run. This new restraints set was exported to the project m 
CCPNMR and was used to modify and refine the previous peak assignments. 
There are several parameters that could be used to check the quality of the structure 
ensemble generated after each ARJA run. The quality analysis report of the structure 
ensemble after each ARJA run will supply the NMR structure quality parameters 
information, such as the pairwise root-mean-square deviation (RMSD) between backbone 
atoms and all atoms of the 10 refined conformers, the Ramachandran plot of the 10 
refmed conformers etc. 
The number ofthe violation restraints can also be thought of as the indicator of how the 
ARJA refinement is progressing. Together, here we report and analyze the fmal refined 
structure ensemble of CSP-ABAB with 35 restraints violations of 536 distance restraints 
with the distance cut-off as 0 Angstrom. 
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4.3 Structure analysis of the calculated structure ensemble 
After the last (8th) iteration and the water refinement procedure, the structure ensemble 
of the 10 water refined conformers were superimposed and are shown in [Figure 4.6]. 
The N- and C- termini and the central region display more structure variability and less 
structure convergence according to the superimposed 10 conformers. The structural 
statistics analysis of the 10 CSP-ABAB conformers and the restraints violations check 
were performed by CNS. The quality report is listed in [Table 4.6]. The energy 
minimized average structure ofthe 10 conformers is presented in [Figure 4.7, 4.8, 4.9]. 
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Figure4.6. The 10 water refined structure models of CSP-ABAB were superposed 
with only the backbones displayed. The residues at the N-/C-terminal Pro 1 and Gly44 
are labeled respectively. 
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Table 4.5. Structural statistics for CSP-ABAB structure ensemble 
Number residues 
Structural Restraints 
Total NOE-derived distance restraints 
Intraresidue (li-ji)=O 
Sequential(li-j I)= 1 
Short(2 ~ li-jl ~ 3) 
Short range & non-sequential 
Long range(li-jl>4) 
Dihedral constraints 
Phi 
Psi 
Statistics for accepted structures 
Accepted structures 
Mean CNS energy terms 
E total (kcal mo[1 ±D) 
E van der waals (kcal mot1 ±D) 
Restraint violations >0.3 A (average# per structure) 
RMS deviations from the ideal geometry used within CNS 
Bond lengths (A) 
Bond angles C ) 
Improper angles ( o ) 
Vander waals (kcal mor') 
Dihedral angles ( o ) 
Ramachandran Statistics (PROCHECK) 
Most favored (%) 
Additionally allowed (%) 
Generously allowed (%) 
Disallowed (%) 
Averaged atomic RMS deviations from average structure 
(+SD) 
Backbone atoms, all residues 
(N,Ca,Co and 0 atoms, all residues, A) 
Heavy atoms, all residues (A) 
Backbone atoms, 2nd structure 
(N,Ca,Co and 0 atoms, 2nd structure, A) 
Heavy atoms, 2nd structure (A) 
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44 
536 
108 
179 
220 
58 
29 
34 
34 
10 
(-1267.82 ±73.1817) 
(-408.307 ± 5.49951) 
0.4 
0.006024 (±0.00036) 
0.88 (±0.037) 
2.29509 (±0.22) 
51.25 (±5. 42) 
40.15 (±0.16) 
84.8 
13.2 
1.75 
0.25 
1.65301 (±0.738222) 
2.39697 (±0.700868) 
0.911885 (±0.388205) 
1.90121 (±0.434217) 
Figure 4.7. The energy minimized average (em_ave) structure of the 10 conformers 
is represented as secondary structure. The residues are colored in residue type. Proline 
and Glutamine are colored green. Glycine, Alanine and Leucine are colored white. 
Arginines are colored blue. Glutamic acids are colored red. The four Alanine (Ala8, 
Ala12, Ala30, Ala34) align at the center ofthe hydrophobic interface ofthe anti-parallel 
helical segments. 
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Figure 4.8. The hydrophobic interface of the energy minimized average (em_ave) 
structure of the 10 conformers. The residues are colored based on residue type. Proline 
and Glutamine are colored green. Glycine, Alanine and Leucine are colored white. 
Arginines are colored blue. Glutamic acids are colored red. The four Alanine (Ala8, 
Ala12, Ala30, Ala34), together with the hydrophobic part of the Glutamic acids forms the 
hydrophobic interface of the anti-parallel helical segments. The negatively charged part 
ofthe Glutamic acids (Oxygen atoms) are exposed on the surface. The Arginine residues 
are mostly extended outward to the aqueous environment, sometimes exposed on the 
surface. 
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Figure 4.9. The hydrophobic ridge of the energy minimized average (em_ave) 
structure. The residues are colored based on residue type. Proline and Glutamine are 
colored green. Glycine, Alanine and Leucine are colored white. Arginines are colored 
blue. Glutamic acids are colored red. The four Alanine (Ala8, Alal2, Ala30, Ala34), are 
in sphere representation. The twelve Leucine residues are in licorice representation. All 
the twelve Leucine residues are exposed on the surface to form the hydrophobic ridge. 
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The energy-minimized structure, together with each ofthe superimposed 10 conformers, 
contains a helix-turn-helix conformation and there are ~ 27 helical residues of the total44 
residues. Based on the superimposed structure ensemble of the 10 conformers and the 
averaged structure of the ensemble, we can see that the two termini and the central region 
of the protein show a dynamic structure and flexibility. The central region of all the 10 
conformers shows the loop/turn conformation, which is highly consistent with the residue 
type located at this region. The hydrophobic residues at this region supply a driving force 
for the two segments to curve and form a hairpin structure. Other than the inter-helical 
hydrophobic stabilization interactions, there are a couple of inter/intra-helical salt bridge 
interactions present in each individual structure conformer and the energy minimized 
averaged structure. These inter/intra salt bridge interactions contribute to the global fold 
ofthe CSP-ABAB and maintain the hairpin conformation. They sit on the surface ofthe 
helical segment. These inter-/intra-helical salt bridge pairs are present together with each 
individual structure conformer respectively in [Figure 4.10, 4.11, 4.12, 4.13, 4.14, 4.15, 
4.16, 4.17, 4.18, and Figure 4.19]. The Ramachandran plot ofthe 10 refmed conformers 
is shown in [Figure 4.20]. 
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Figure 4.10 Structure conformer one and its salt bridges. The salt bridges are 
represented as blue dotted line. The atoms contributing to the salt bridges are labeled 
green. There are four salt bridge pairs formed on this conformer. GLU26-ARG29, 
GLU27-ARG20, GLU27-ARG31, GLU37-ARG33. 
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Figure 4.11 Structure conformer two and its salt bridges. The salt bridges are 
represented as blue dotted line. The atoms contributing to the salt bridges are labeled 
green. There are six salt bridge pairs formed on this conformer. GLU5-ARG31, GLU15-
ARG11 , GLU37-ARG7, GLU37-ARG40, GLU38-ARG42, GLU41-ARG7. 
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Figure 4.12 Structure conformer three and its salt bridges. The salt bridges are 
represented as blue dotted line. The atoms contributing to the salt bridges are labeled 
green. There are three salt bridge pairs formed on this conformer. GLU4-ARG42, 
GLU26-ARG20, GLU27-ARG9. 
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Figure 4.13 Structure conformer four and its salt bridges. The salt bridges are 
represented as blue dotted line. The atoms contributing to the salt bridges are labeled 
green. There are two salt bridge pairs formed on this conformer. GLU5-ARG9, GLU37-
ARG11. 
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Figure 4.14 Structure conformer five and its salt bridges. The salt bridges are 
represented as blue dotted line. The atoms contributing to the salt bridges are labeled 
green. There are four salt bridge pairs formed on this conformer. GLU4-ARG7, GLU15-
ARG33, GLU26-ARG20, GLU38-ARG9. 
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Figure 4.15 Structure conformer six and its salt bridges. The salt bridges are 
represented as blue dotted line. The atoms contributing to the salt bridges are labeled 
green. There are five salt bridge pairs formed on this conformer. GLU4-ARG7, GLU5-
ARG31, GLU27-ARG9, GLU37-ARG40, GLU38-ARG31. 
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Figure 4.16 Structure conformer seven and its salt bridges. The salt bridges are 
represented as blue dotted line. The atoms contributing to the salt bridges are labeled 
green. There are four salt bridge pairs formed on this conformer. GLU4-ARG11, GLU27-
ARG11, GLU38-ARG11, GLU38-ARG31. 
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Figure 4.17 Structure conformer eight and its salt bridges. The salt bridges are 
represented as blue dotted line. The atoms contributing to the salt bridges are labeled 
green. There are three salt bridge pairs formed on this conformer. GLU5-ARG31, 
GLU15-ARG33, GLU38-ARG31. 
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Figure 4.18 Structure conformer nine and its salt bridges. The salt bridges are 
represented as blue dotted line. The atoms contributing to the salt bridges are labeled 
green. There are four salt bridge pairs formed on this conformer. GLU5-ARG9, GLU16-
ARG33, GLU26-ARG20, GLU27-ARG9. 
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Figure 4.19 Structure conformer ten and its salt bridges. The salt bridges are 
represented as blue dotted line. The atoms contributing to the salt bridges are labeled 
green. There is only one salt bridge pair formed on this conformer. GLU5-ARG31. 
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Figure 4.20 Ramachandran plot of the 10 water refined conformers of CSP-ABAB. 
The Ramachandran plot was generated by MOlMOL for the 10 refmed conformers. 
Glycine residues are displayed as cross, all other types of residues are shown as dot. Of 
the 440 residues, including 20 glycine and 20 proline, 84.3% fall in the most favored 
region (green), 13.2% in allowed regions (yellow), 1.75% in additionally allowed regions 
(pink), and 0.25% in disallowed regions (white). 
- 115-
The twelve leucine residues are aligned along the whole hairpin and form a hydrophobic 
ridge of the whole hairpin [Figure 4.9]. The 5 residues Leu21-Ala25 finish the hairpin 
turn nicely with a hydrophobic area formed around the adjacent proline kink created by 
Pro23. The glutamic acid residues form two clusters at the kink area and the N-/C-termini 
area. These glutamic acid residues are buried in the hydrophobic network formed 
between the anti-parallel helical segments. Ala8, Ala12, Ala30 and Ala34 sit in the center 
of the inter-helical hydrophobic network. The arginine residues are present on the 
molecule surface and mostly stick outward to the hydrophilic aqueous environment. 
The four alanine pairs are buried between the two helices, sometimes leaving some 
space for the neighboring arginine to curve in and form an inter-helical salt bridge as in 
[Figure 4.16]. The loose hydrophobic area formed by the four alanine residues could 
provide a possibility for lipid to access and open up the inside hydrophobic network. All 
the arginine residues and the electrostatic interactions (salt bridges) are present on the 
surface of the anti-parallel segments to minimize the exposed hydrophobic ridge formed 
by the twelve leucine residues. This hydrophobic ridge formed by the twelve leucine 
resudues could bind around the lipid particle initially when lipids are introduced. 
The helical segments formed in each individual conformer are very conserved. The 
energy minimized averaged structure shown here represents the structure adaptability of 
each individual residue in solution and also shows the propensity of each residue's 
minimized energy conformation. The molecular features ofthis structure also shed some 
light on the interaction mechanism of the CSP-ABAB with the lipids or protein particle. 
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Taken together,the hydrophobic interaction between the anti-parallel helical segments 
provide the major driving force for the formation of the anti-parallel hairpin conformation 
in the lipid free aqueous environment over other types of interactions. 
The intra-/inter-helical salt bridges of CSP-ABAB also play a important role in 
stabilizing the global antiparallel hairpin conformation. These electrostatic interactions 
also result in a hydrophilic surface, minimizing the energy of the molecule in the lipid 
free aqueous environment. 
In the presence of lipids, the exposed hydrophobic ridge composed of the leucine 
residues will avidly bind to lipids. The buried four alanine residues that lie between the 
two helical segments probably will bind to the lipids due to the slightly spacious interface 
among them which is very accessible for the introduced lipids. These lipid binding could 
open the helical hairpin to form a belt binding around the lipids. Following the lipid 
binding, the helical content of the protein may increase according to the CD data acquired 
from the synthetic CSP-ABAB [Chao Y, 20031 . The residues on the loop like Leu24 to Leu28 
will probably become helical after the opening of the hairpin conformation as suggested 
by the secondary structure prediction results by Talos+ in [Table 4.5]. The two initial 
lipid binding steps open the anti-parallel helical hairpin conformation to form a fully 
extended a-helix. Similar hydrophobic inter-helical stabilization interactions and new 
intra-/inter-helical salt bridges between two different CSP-ABAB molecules are reformed 
to stabilize the 'double-belt' arrangement around the lipid particle core. 
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Chapter 5 Summary and discussion 
5.1 Summary of this thesis study 
In this study, I successfully expressed and purified the recombinant CSP-ABAB 
peptide. The secondary structure was investigated primarily through a series of CD 
experiments. The concentration of this peptide was determined by amino acid analysis. 
With the accurately determined concentration, the CD data results can be used 
quantitatively. The CD data indicated that the major conformation of the protein is a-
helix and the helical content is ~62%, i.e.~27 residues of 44 residues are helical. The 
protein does not self-associate within the concentration range from 0.005 mg/mL to 1 
mg/ml although the hydrophobic residue content of the protein is ~45%. 
More molecular structural details of this peptide were explored through 15N and 13C 
labeling the protein and a series ofNMR experiments were carried on the isotope labeled 
CSP-ABAB. The degenerate sequence of CSP-ABAB presented a significant problem for 
the first step of backbone resonance assignment, and an even harder problem for the 
further side-chain resonance assignment. With tedious assignment and reassignment, the 
backbone and side-chain resonances of the 44 residues of the peptide were successfully 
assigned. With the assigned chemical shifts, the dihedral and distance restraints were 
generated, the initial structure calculation and following refmement was carried out. Ten 
water refmed structure conformers and one energy minimized average structure of the 
NMR structure ensemble were generated and presented in Chapter 4. The NMR structure 
of CSP-ABAB displays a global helix-turn-helix conformation in solution. Hydrophobic 
interaction of the residues located at the interface between the two helical domains play a 
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major role in stabilizing the anti-parallel helical hairpin conformation. Intra-/inter-helical 
salt bridges of the molecular surface also help stabilize the overall anti-parallel 
conformation. However, the exact helical content and the global fold is variable due to 
the low stability of this conformation. Therefore, the intra-/inter-helical salt bridge pairs 
varied in each individual structure conformer. 
Theoretical, sequence analysis of the AB consensus sequence suggested a couple of 
potential intra-helical salt bridge pairs between residue pair (i,i+4) and (i,i+ 3) when the 
AB sequence was displayed on the helical wheel [Nolte and Atkinson, !992. Mei and Atkinson,2011 
[Figure 5.1]. The salt bridge pairs Glu5-Arg9, Argll-Glu15, Glu16-Arg20 are thought to 
play important roles in stabilizing the AB repeat. Glu4-Arg7, Glu15-Arg18 pairs are 
suggested to supply additional stabilization. The triad salt bridge Argll-Glu15-Arg18 
was believed to be the strongest contributor to the stability. 
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Figure 5.1 The helical wheel view of the suggested salt bridge pairs of CSP-AB 
sequence. The acidic residues are colored red, the basic residues are colored blue, the 
hydrophobic residues were colored white, neutral residue like Gln13 and Gln35 are 
colored green. Salt bridge pair of residues (i,i+4) are displayed in purple, salt bridge pair 
f .d c· · 3) d. l d · bl (Mei X, Atkinson D 2011] o rest ues 1,1+ are 1sp aye m ue. ' 
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The potential suggested salt bridge interactions were present in the two helical segments 
of each individual conformer with slightly alterations [Table 5.1] . Specifically, on 
conformer one, the triad salt bridge Arg20-Glu27-Arg31 (i, i+4) stabilizes the second 
helical segment and inter-segment interactions on conformer one. There are two 
additional two single salt bridge Glu26-Arg29, Glu37-Arg33 (i, i+3) pairs that stabilize 
the second helical segment. On conformer two, the triad salt-bridges Arg40-Glu37-Arg7 
(i,i+3), Glu37-Arg7-GLu41 (i,i+4) provide stabilization for the inter-helical interactions. 
There are additional single inter-helical salt-bridge Glu5-Arg31 and two intra-helical salt-
bridges Glu15-Argll and Glu38-Arg42 (i,i+4). On conformer three, three inter-helical 
salt-bridges Glu4-Arg42, Glu26-Arg20, Glu27-Arg9 stabilize the anti-parallel 
conformation. On conformer four, one intra-helical salt-bridge Glu5-Arg9 (i,i+4) and one 
inter-helical salt-bridge Glu37-Argll provide the intra-/inter-helical stabilization. On 
conformer five, three inter-helical salt-bridge Glu15-Arg33, Glu26-Arg20 and Glu38-
Arg9 and one intra-helical salt-bridge Glu4-Arg7 (i,i+ 3) stabilize the anti-parallel helical 
conformation. On conformer six, there is one triad salt-bridge Glu5-Arg31-Glu38 (i,i+7) 
that provides the intra-/ inter-helical stabilization. There are one additional inter-helical 
salt-bridge Glu27-Arg9 and two intra-helical salt-bridges Glu4-Arg7 and Glu37-Arg40 
(i,i+3). 
On conformer seven, there is a salt-bridge network present through the center of the 
anti-parallel helical interface, which suggests the low stability and high accessibility of 
the site formed by the four alanine residues (Ala 8, 12, 30, 34). The salt-bridge network is 
contributed by three triad salt-bridges, Glu4-Arg11-Glu27 (i,i+7), Glu4-Argll-Glu38 
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(i,i+7), Argll-Glu38-Arg31 (i,i+7). On conformer eight, two inter-helical salt-bridge 
Glu5-Arg31 , Glu15-Arg33 and one intra-helical salt-bridge Glu38-Arg31 (i,i+7) stabilize 
the anti-parallel helical conformation. On conformer nine, one triad salt-bridge Glu5-
Arg9-Glu27 (i,i+4) and two inter-helical salt-bridges Glul6-Arg33 and Glu26-Arg20 
provide the inter-/intra-helical stabilization. On conformer ten, there is only one inter-
helical salt-bridge Glu5-Arg31 , which provides the inter-helical stabilization for the anti-
parallel helical conformation of CSP-ABAB. 
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Table 5.1 Salt bridge interactions present in each individual structure conformer. 
Structure Residue Distance (A) Residue 
Conformer one Glu26 3.45 Arg29 
Glu27 4.14 Arg20 
Glu27 4.62 Arg31 
Glu37 4.59 Arg33 
Conformer two Glu5 3.6 Arg31 
Glu15 4.45 Arg11 
Glu37 3.74 Arg7 
Glu37 4.1 Arg40 
Glu38 4.49 Arg42 
Glu41 4.71 Arg7 
Conformer three Glu4 4.26 Arg42 
Glu26 3.86 Arg20 
Glu27 4.01 Arg9 
Conformer four Glu5 3.37 Arg9 
Glu37 4.38 Arg11 
Conformer five Glu4 3.36 Arg7 
Glu15 3.3 Arg33 
Glu26 3.61 Arg20 
Glu38 4.55 Arg9 
Conformer six Glu4 3.43 Arg7 
Glu5 3.52 Arg31 
Glu27 3.5 Arg9 
Glu37 3.39 Arg40 
Glu38 4.45 Arg31 
Conformer seven Glu4 4.68 Arg11 
Glu27 4.2 Arg11 
Glu38 3.91 Argll 
Glu38 3.35 Arg31 
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Table 5.1 Continued. 
Structure Residue Distance (A) Residue 
Conformer eight Glu5 3.3 Arg31 
Glu15 3.83 Arg33 
Glu38 4.19 Arg31 
Conformer nine Glu5 4.44 Arg9 
Glu16 4.49 Arg33 
Conformer ten Glu26 3.48 Arg20 
Glu27 4.2 Arg9 
Glu5 3.27 Arg31 
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5.2 Comparison of the NMR structure with the structures solved by dynamic 
simulation 
Although the CD data of the expressed CSP-ABAB in this study contains ~62% a-
helical content. , the crystallographic study of the synthetic CSP-ABAB by Chao [Chao Y, 
20031 suggested that the CSP-ABAB peptide has ~87% a-helical content and the CSP-
ABAB employs a helix-turn-helix conformation. Luo carried out a molecular dynamics 
simulation (MD) study of the solution structure of CSP-ABAB and CSP-AB [Luo D, 20091. 
The dynamics simulation of CSP-AB and CSP-ABAB shows that the a-helical structure 
is the most stable and the only secondary structure motif in solution. The intra-domain 
and inter-segment interactions stabilize the structure. 
In the dynamic simulation study of CSP-AB, two stable helical segments formed. Each 
contained ~ 7 residues. The salt bridges formed between Arg 7, 11 and Glu 16, 19 
stabilize the two-helix conformation, which was further confirmed by salt bridge 
disruption observed during the simulation experiments with Glu16 and/or Glu19 
protonated. The two segments merged into one helical domain after neutralizing Glu 19, 
which was further facilitated if the Glu16 was neutralized. The standard a-helix 
conformation containing mostly i->i+4 hydrogen bonds transformed to the n -helix 
conformation with mostly i->i+5 hydrogen bonds. However, a similar salt bridge 
interaction pattern with residue (i) -> residue (i+3/4) still predominated. [Table 5.2] 
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Table 5.2 Salt bridge interactions pattern present in the structure by dynamic 
simulation. 
Intra segment salt bridge interaction Inter segment salt bridge interaction 
Glu 5 --- Arg 9 Glu 4 --- Arg 42 
Glu 4 --- Arg 7 Arg 7 --- Glu37 --- Arg 11 
Arg 11 --- Glu 15 --- Arg 18 Arg20 --- Glu16 --- Arg 33 
Arg 29 --- Glu 26 
Arg 31 --- Glu 27 
Glu 37 --- Arg 33 
Arg 42 --- Glu 38 
The molecular dynamics simulation of CSP-ABAB [Luo, D, 20091 shows consistent results 
with the structure information previously suggested by the crystallographic study [Chao, Y, 
20031. Two a-helical segments were formed with the loop in the middle, centered at Pro23. 
The helical domains were quite stable. The fmal two structures generated from the 
simulation studies show similar helix-loop-helix conformation. [Figure 5.2] The two 
helical segments aligned with helix axis angles of - 20 ° (model 1) and 10 ° (model 2), 
respectively. 
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Modell 
Model2 
Figure 5.2 CSP-ABAB structures generated by dynamic simulation. fLuo D, 20091 
Residues are colored according to residue type. Acidic residues are red, basic residues are 
blue, Pro/Gin are green, Leu/Gly are white. The charged residues are also represented as 
line. 
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The a -helix content determined by DSSP [Kabsch w, et al , 1983] was ~ 70%, almost 10% more 
than the a-helix content of 62% measured by CD of the expressed CSP-ABAB. However 
it is ~10% less than the a-helix content of 80% measure by Chao for the synthetic CSP-
ABAB. 
Both structures generated from the simulation had a hydrophobic loop and a hydrophilic 
side formed from the two opposite sides ofthe helix-loop-helix hairpin. Residues Leu21, 
Gly22, Pro23, Leu24, Ala25 and Leu28 were present on the loop. Leu17 and Ala30 were 
also on the extended central loop. The two helices ofthe helical hairpin had a hydrophilic 
surface and formed four intra-helical salt bridges in a similar pattern. They also formed 
four inter-helical salt bridges as follows: Arg7-Glu37, Arg 7-Glu41, Arg11-Glu37 and 
Glu16-Arg33 in both structures generated. 
In summary, the hydrophobic residues located at the center of the peptide drive the 
formation ofthe hairpin, the salt bridges and the hydrophilic surface formed from the side 
chains of the two helices stabilized the whole helix-loop-helix conformation. The 
hydrophobic residues on the two helical segments provide the potential interface to 
interact with the lipids in solution. 
Although CSP-ABAB contains ~45% hydrophobic residues, CSP-ABAB in solution 
does not self-associate within the concentration range of 0.05 mg/ml to 1 mg/ml as 
confirmed by the CD experiments. The dynamics simulation results of the oligomer of 
CSP-ABAB are consistent with the CD results. The simulation results showed the CSP-
ABAB monomer is very stable and well stabilized by the salt bridge pairs and hydrogen 
bonds In the simulated CSP-ABAB dimer, the inter-molecular salt bridge interactions are 
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still the main force to stabilize the whole structure. In the simulated CSP-ABAB tetramer, 
less salt bridge interactions are present but more hydrophobic inner space among the 
oligomer was formed, which suggests that at higher concentration, CSP-ABAB may have 
the propensity to hide the hydrophobic residues to form a hydrophobic space in the 
oligomer and expose a polar surface to the aqueous environment, as in the case of the 
crystal formation in the crystallographic study carried out by Chao [Chao Y, 20031. 
However, the tightly packed model in the crystal structure is defmitely not the same as 
in the dynamic polar aqueous environment of the dynamics simulation or the solution 
environment of the NMR study. In the polar aqueous environment or NMR study 
aqueous environment, the CSP-ABAB monomer does not self-associate and the 
monomer is very stable with the strong intra/inter-helical stablization interactions. 
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5.3 Comparison of the NMR structure of CSP-ABAB with the ..1.(185-243) apoA-1 
structure solved by X-ray crystallography 
As illustrated in the apoA-1 sequence map in Chapter 1, apoA-1 contains a series of AlB 
homology sequences : H1 (BB), H2 (AA), H3 (B), H4 (AB), H5 (AB), H6 (AB), H7 
(AB), H8 (BB), H9 (A) and H1 0 (BB). Totally, apoA-1 has 5 AB homology sequence 
repeats : AB1 (H2/H3), AB2 (H4), AB3 (H5), AB4 (H6) and AB5 (H7). In the ~(185-
243) apoA-1 structure solved by x-ray crystallography [Figure 5.3], two molecules of 
~(185-243) apoA-1 form a symmetrical semi-circular dimer, with the two apoA-1 
monomers paired in a manner similar to the two segments of CSP-ABAB. Like the NMR 
structure of CSP-ABAB, the AB1, AB2, AB4 and AB5 regions are stabilized by inter-
helical salt bridges between the two apoA-1 monomers and intra-helical salt bridges 
within the monomer. Two major (N-termini and C-termini) salt bridge networks 
composed of the intra- and inter- salt bridge hold the apoA-1 dirner together. All the 
intermolecular salt bridges are situated on the outside surface ofthe backbone formed by 
the five AB repeats, which results in a hydrophobic inside surface between the two apoA-
1 monomers. There are no inter-helical salt bridge interactions between the juxtaposed 
AB3 repeats (residues 121-142). 
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Outside 
Top view 
C-lnter Salt Bridges 
Side view 
Exon 3 Encoded RegkM'I (1-43) 
CSP A ttomotogy Sequenc:t~ 
CSPB-Soquonco 
PrOline 
Figure 5.3 d (185-243) apoA-1 structure solved by X-ray crystallography and the 
salt bridges between the two apoA-1 monomers [Mei x, Atkinson °· 20111 . PDB ID: 3R2P. 
Region (1-43) is green, consensus sequence A and B homology sequences are in purple 
and cyan. Proline residues are labeled in yellow. The top inset window displays the C-
terminal inter-monomer salt bridges; the bottom inset window displays the N-terminal 
inter monomer salt bridges. 
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The central segment hinge region AB3 (H5, residues 121-142) of apoA-1, is situated in 
the middle of the semi-circular circle backbone. It is different from the other AB 
sequence repeats ofapoA-1, as there are no inter molecular salt bridges between the AB3 
repeats. This feature was suggested to enhance the flexibility of the hinge region of the 
apoA-1 dimer and may contribute to the lipid binding function. The crystal structure also 
clearly shows a central hole with ~5 angstrom diameter formed by the opposition of 
Al30 on the two anti-parallel AB3 regions. This was believed to be a tunnel responsible 
for opening up the inside hydrophobic surface and interacting with lipids. 
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Figure 5.4 Salt bridge interactions details within the A (185-243) apoA-1 monomer. 
The acidic residues are colored red, the basic residues are colored blue, the hydrophobic 
residues were colored white, neutral residue like Q/N/S/T are colored green. Salt bridge 
pair of residues (i,i+4) are displayed in purple, salt bridge pair of residues (i,i+ 3) are 
displayed in blue. [Mei x, Atkinson D, 2011] 
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Further details of the intra-helical salt bridge interactions of the five AB repeat units of 
the apoA-1 monomer are illustrated in [Figure 5.4]. The ABl regions have three salt 
bridges: K88/E85, E92/K96 and K88/D89. The AB3 region has one intra-helical salt 
bridge E128/R131 and one intra-helical triad salt bridge K133/E136/K140. The AB2 
region has one single salt bridge, E113/R116 and one relay salt bridge, 
K106/E110/K107/Elll. The AB4 region has two salt bridges, E147/R151 , E146/R149 
and one triad salt bridge, R153/D157/R160. The AB2 and AB4 regions are more 
stabilized with the triad or relay salt bridge. The AB5 region has two salt bridges, 
E 179/K182 and E 169/R173. 
Similar to the X-ray structure ofthe truncated apoA-1, most potential salt bridges pairs 
suggested by the sequence analysis are present in the NMR structure conformers. The 
formed intra-/inter-helical salt bridge pairs sit on the outside surface of the molecule, 
which results in a hydrophobic inside surface between the two helical segments of CSP-
ABAB. There is also a space left among the four alanine residues aligning at the interface 
of the anti-parallel helices of CSP-ABAB, which is suggested to be the binding site for 
the lipids and be responsible for opening up the inside hydrophobic interface. Therefore, 
the electrostatic surfaces ofthe structural conformers and the energy-minimized averaged 
structure are stable in the lipid free aqueous environment. [Figure 5.5] 
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Figure 5.5 Hydrophobicity representation of the surface of CSP-ABAB The most 
hydrophilic is colored in blue, to white and the most hydrophobic is colored in orange 
red. Top left and bottom left are the front and back view of the CSP-ABAB surface. 
Right is the side view ofthe CSP-ABAB surface. The hydrophobic area ofthe surface is 
the leucine residues. The hydrophilic area of the surface is contributed by the charged 
atoms ofthe arginine and the salt-bridge pairs. 
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5.4 Lipid binding model proposed based on the NMR structures of CSP-ABAB 
In lipid free solution, the CSP-ABAB contains a globular antiparallel amphipathic 
helical pair where hydrophobic lipid-binding regions are stabilized by inter-helical 
hydrophobic interactions. The hydrophobic residues (Ala8, Ala12, Ala30, Ala34) 
completely or partially align in the inner space between the two anti-parallel helical 
segments and increase the protein's lipid binding adaptability. The remarkable structural 
adaptability of CSP-ABAB is consistent with its low stability and its lipid binding 
function. Based on the so lution structural features we derived from the NMR data, we 
proposed a lipid-binding hypothesis for CSP-ABAB and potentially for most 
exchangeable apolipoproteins [Figure 5.6]. 
For this hypothesized lipid binding model, the residues located in the structurally 
dynamic region (Leu24Ala25Glu26Glu27) between the two AB helical segments adopt 
different conformations in the 10 water refined conformers. They employ a turn 
conformation. This region is the least convergent region of the whole CSP-ABAB 
sequence based on the superimposed structure ensemble [Figure 4.6]. The different 
conformations in this turn suggest that this region may be dynamic and sampling multiple 
conformations, but additional NMR-relaxation experiments are required to test this 
hypothesis. 
When lipids are introduced, there are two possible ways to disrupt the anti-parallel 
helical conformation. First, the exposed hydrophobic ridge contributed by the twelve 
leucine residues may first bind to lipid. At the same time, the hydrophobic concave 
surface (or hole) created by the four alanine residues lining the interface will become 
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accessible to the lipids [Figure 5.5]. Theses two initial lipid binding steps will overcome 
and disrupt the previously formed hydrophobic stabilization interactions between the 
anti-parallel helical segments and further open up the anti-parallel helices. 
The salt bridge interactions present on the lipid-free CSP-ABAB may be disrupted 
between the two anti-parallel AB helical segments within one CSP-ABAB monomer and 
then be reformed between two anti-parallel AB helical segments from two CSP-ABAB 
molecules once bound to the lipid disk. 
The whole CSP-ABAB molecule will extend to a long amphipathic helix with two 
helical segments (Ala3-Arg18 and Leu24-Arg38), which was confirmed by the CD 
experiments of the synthetic CSP-ABAB carried out by Chao [Chao Y, 20031 . The a-helical 
content increase to around 90% after BOG or TFE was introduced to the CSP-ABAB in 
solution. These long amphipathic helix monomers will bind to the lipid disk as 'double 
belt' together with another fully extended CSP-ABAB monomer when the two anti-
parallel helical pairs completely open the helical bundle and fully extend to a long 
amphipathic helix. Hydrophobic inter-helical interactions are similarly formed again 
between two AB helical segments, but from two different CSP-ABAB molecules. These 
hydrophobic interactions, together with the reformed salt-bridge interactions, stabilize the 
"double belt" arrangement of CSP-ABAB molecules around the lipid disk. 
This lipid binding hypothesis is also consistent with the helical arrangement pattern 
'h' h C · 1 d Aid' X t [MeiXAtkinsonD2011] F' w1t m t e -termma truncate apo - Imer -ray struc ure · · . 1gure 
5.6 is the proposed secondary structural model of CSP-ABAB binding lipids (BOG or 
TFE). This model is proposed based on the structural features present on the NMR 
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structures, which is also based on the a-helical content results derived from the CD data 
ofthe synthetic CSP-ABAB. In all, CSP-ABAB can bind and solubilize lipid readily. 
5.5 Discussion of the limitations of the NMR structure ensemble 
The quality ofthe two three-dimensional 15N HSQC-NOESY and 13C HCCH-TOCSY 
spectra are not very satisfactory due to the degenerate sequence of CSP-ABAB and the 
resultant severe peak overlapping problem. The side-chain resonance assignment is not as 
solid as the backbone resonance assignment. However, the secondary structure 
information of CSP-ABAB reported in this dissertation is based on a valid assignment 
and convincing. Nevertheless, the three-dimensional NMR structure ensemble reported in 
this dissertation suffers uncertainty, which may have arisen from incorrect side-chain 
resonance assignment. 
There was a previously generated NMR structure ensemble reported in the first version 
of this dissertation. Both the previous and currently reported structure ensemble is based 
on the same backbone and most of the same side-chain resonance assignments. However, 
there was only one inter-helical NOE (42Arg-1Pro) tentatively assigned and used for the 
previous structure calculation. This calculation resulted in a structure ensemble with an 
inter-helical salt-bridge network and largely exposed hydrophobic surface. The structures 
were not biological reasonable or energetically favorable. 
Reexamination of the 15N HSQC-NOESY and determination of more long range (> i, 
i+7) NOEs (namely, 16GluHf3b-27GluH, 38GluHa-5GluH, 42ArgHya-5GluH and 
41GluHf3a-5GluH) contributed to this new set ofNMR structure in which the energy was 
much more minimized. These long range NOEs contribute to the refmed three-
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dimensional NMR structure ensemble reported in this dissertation, and help defme the 
anti-parallel conformation ofCSP-ABAB. 
Other than these important newly assigned NOEs, there are also short range NOEs 
(i,i+4) among the alanine residues, 8Ala-12Ala and 30Ala-34Ala, that help defme the 
overall anti-parallel hairpin conformation. The possible cross peaks between 8Ala-34Ala 
and 12Ala-30Ala, are left unassigned simply because the 15N chemical shift difference 
between 8Ala/30Ala, and 12Ala/34Ala are not large enough and the peaks not well 
separated in the three-dimensional 15N HSQC-NOESY spectrum [Figure 3.4]. It proved 
difficult to defme whether the cross peaks are from the short range alanine pairs (8Ala-
12Ala, 30Ala-34Ala) or from the long range alanine pairs (8Ala-34Ala, 12Ala-30Ala). 
The reason to replace the previous structure ensemble and report this newly generated 
NMR structures instead is because the new structure ensemble set are much more 
biologically reasonable and energetically favorable in a lipid-free aqueous environment. 
As described in Chapter 5, in this NMR structure ensemble, all the hydrophilic atoms and 
electrostatic interactions are exposed on the surface minimizing the exposed hydrophobic 
surface resulting from the twelve leucines. Thus, the new set of structures is more energy 
minimized than the prior set. And the new structure calculation is based on additional 
new assigned unambiguous long range NOEs. Thus the new set of NMR structures 
reported in this dissertation are believed to be better and more likely to be correct than the 
original set in terms of the energy, stability and the calculation process. 
Prior structure ensemble E total (kcal mor1 ±D) (-1199.64±121.068) 
Current structure ensemble E total (kcal mor1 ±D) ( -1267.82±73.1817) 
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Although the limitations of the three-dimensional spectra result in some uncertainty in 
the side chain assignment and the uncertainty of the reported NMR structure ensemble, 
longer 15N HSQC-NOESY or 13C HCCH-TOCSY experiments, and additional three-
dimensional NMR experiments may help resolve these uncertainties in the side-chain 
assignment and further validate the structures presented. 
5.6 Future studies 
Future studies may consist ofthe following two aspects. 
The limitation of this study arise from the lack of enough clear side-chain resonances 
assignments due to the severe peak overlapping problem of the three-dimensional HSQC-
NOESY spectra and HCCH-TOCSY spectra. These issues result in the inaccuracy of the 
side chain assignment and invalidity of the determined structures. To validate the NMR 
structures here, longer HSQC-NOESY or HCCH-TOCSY experiments, and additional 
experiments to validate and extend the current assignments can help resolve the 
uncertainty of the assignments and increase the validity of the structures. 
Our long-term goal is to understand the protein-lipid interaction. Although the lipid 
binding model of CSP-ABAB is proposed here, CD experiments of the lipid-peptide 
complex and NMR experiments of the lipid-peptide complex will give more clear 
information about the lipid binding process of CSP-ABAB and also the exchangeable 
apo lipoproteins. 
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lipid-free form 
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Figure 5.6. Proposed lipid binding model of CSP-ABAB. Two anti-parallel helical 
segments completely open the anti-parallel helical pair to form a fully extended a-helix. 
Similar hydrophobic inter-helical stabilization interactions (represented as orange) are 
reformed between the two AB helical segments but from two different CSP-ABAB . 
molecules to stabilize the 'double-belt' arrangement. The binding site ofthe CSP-ABAB 
molecules with the lipid surface is the hydrophobic surface contributed by the twelve 
Leucine residues, which was original exposed to the lipid-free aqueous environment. 
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